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Dynamic histone modification has emerged as a robust and versatile regulator of 
gene expression in eukaryotic cells. One such modification, the trimethylation of lysine 27 
on histone H3 (H3K27me3) is facilitated by the Polycomb repressive complex 2 (PRC2) 
and contributes to the localized repression of transcription. Subsequently, lysine specific 
demethylase Kdm6b (Jmjd3) can relieve the repressive H3K27me3 mark, allowing for 
transcriptional activation. In vitro studies have suggested a role for Kdm6b during 
mesodermal and cardiovascular differentiation in mammalian embryonic stem cells; 
however, this relationship has yet to be characterized in vivo. I utilized the advantages of 
the zebrafish model to investigate the in vivo roles of Kdm6b-family demethylases during 
development using a reverse genetic approach.  
I carried out two independent loss-of-function studies to analyze the role of 
Kdm6b-family demethylases during embryonic development in zebrafish. By comparing 
genetic loss-of-function and morpholino-mediated knockdown approaches, I found that 
morpholino–mediated knockdown of kdm6bb transcript produces off-target effects and 
does not portray an accurate representation of in vivo function. I then show that, while not 





redundantly to promote late stage proliferation during heart ventricle trabeculation. These 
data reveal a previously unknown functional relationship and support the hypothesis that 
Kdm6b-family demethylases function primarily during later stages of development. 
Additionally, my description of morpholino-induced off-target effects supports the need to 
use extreme caution when interpreting morphant phenotypes. 
Due to the embryonic lethality exhibited by kdm6b-deficient embryos and the 
limited tools available for spatiotemporal transgene control in zebrafish, I was unable to 
investigate demethylase function within adult animals. I attempted to circumvent these 
limitations by creating an inducible gene expression system that uses tissue-specific 
transgenes that express the Gal4 transcription factor fused to the estrogen-binding domain 
of the human estrogen receptor. I showed that these Gal4-ERT driver lines confer rapid, 
tissue-specific induction of UAS-controlled transgenes following tamoxifen exposure in 
both embryos and adult fish. I then demonstrated how this technology could be used to 
define developmental windows of gene function by spatiotemporally controlling expression 
of constitutively active Notch1 in embryos. 
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 “We had described competence as a state of disequilibrium in a complex system 
of reactants, and had suggested that the reactants are ultimately genes or gene products” 
-C.H. Waddington, 1940 
 
 In a manuscript that predates our understanding of nucleic acid structure and 
function, Conrad Waddington (quoted above) detailed his theories of developmental 
“competence” that are strikingly amenable to our modern understanding of cellular 
specification and differentiation. It was here that Waddington coined the term “epigenetic 
landscape” to describe an unknown mechanism of development that existed “on top” of 
heritable genetics and that could, in effect, either mask or reveal underlying genetic traits. 
This idea has been expounded upon by researchers over the last half-century and has 
given rise to the field of modern epigenetics in which Waddington’s theories of 
development are being applied to the microcosm of molecular genetics. As a corollary, 
the concept of an “epigenetic landscape” has been transformed to fit within our current 
body of knowledge. Contemporary definitions of epigenetic landscape, though still the 
subject of debate, describe any non-genetic mechanism that contributes to the 
transcriptional programing of a cell. To date, researchers have identified several such 
modes of epigenetic gene regulation including covalent histone modification, DNA 
methylation, and chromatin remodeling, which have all been shown to dynamically 





beginning to discover how these mechanisms contribute to vertebrate development and 
homeostasis.   
 
 Post-translational histone modification has emerged as a particularly active area 
of research due, in part, to the complexity arising from the multitude of different 
modifications and target residues. One such example is the trimethylation of lysine 27 on 
histone H3 (H3K27me3). The trimethylation of H3K27 is facilitated by Enhancer of zest 
(Ezh2), a component of the Polycomb repressive complex (PRC2), and contributes to the 
localized repression of transcription (Cao et al., 2002; Margueron and Reinberg, 2011; 
Müller et al., 2002). This repressive mark can subsequently be relieved by lysine specific 
demethylases such as Kdm6a (UTX) and Kdm6b (Jmjd3), thus promoting transcriptional 
activation (Cloos et al., 2008; Klose and Zhang, 2007; Mosammaparast and Shi, 2010). 
Together these processes constitute a dynamic and potentially versatile layer of 
transcriptional regulation; however, the biological significance of this particular 
modification is currently a topic of debate. Numerous genome-wide descriptions of 
H3K27me3 localization suggest chromatin modifiers like EZH2 and Kdm6b have key 
contributions during development, adult tissue homeostasis, and even tissue 
dedifferentiation and regeneration.  
 
 In vitro studies of H3K27 demethylases have described roles for Kdm6b within 
development of all three germ layers, which suggest that localized demethylation may be 
a fundamental mechanism of gene regulation. In mouse and human embryonic stem (ES) 





decorating promoter regions, thereby contributing to the activation of important 
endodermal-commitment markers such as Eomes (Kartikasari et al., 2013; Kim et al., 
2011), WNT3 (Jiang et al., 2013), and Nodal (Kim et al., 2011). Kdm6b-deficient mice 
have also been shown to exhibit defects in endodermal derivatives such as the lung 
(Burgold et al., 2012; Li et al., 2014b); however, the Kdm6b target genes revealed by 
these studies did not coincide with in vitro data. Instead, these mouse models implicated 
Kdm6b in the activation of lung specific genes such as AQP-5 and SB-P (Cao et al., 
2002; Li et al., 2014b; Margueron and Reinberg, 2011; Müller et al., 2002) that represent 
stages of development much later than endodermal commitment.  
 
 Further reports have demonstrated that Kdm6b is required for ectoderm induction 
in embryonic stem (ES) cells (Cloos et al., 2008; Klose and Zhang, 2007; Morales Torres 
et al., 2013; Mosammaparast and Shi, 2010) via regulation of Msi1, Sox1, Otx2 and Pax6. 
Interestingly, a separate study that eliminated both Kdm6b and Kdm6a found no change 
in ectodermal induction (Shpargel et al., 2014), however it is unclear if they probed for 
the presence of the same proteins. In vivo, Kdm6b has also been shown to contribute to 
endochondral bone formation by promoting proliferation and hypertrophy via association 
with Runx2 (Kartikasari et al., 2013; Kim et al., 2011; Zhang et al., 2015). Importantly, 
the Kdm6b-deficient mice generated for this study exhibited perinatal lethality due to 
inability to breathe, which does not reflect the expected phenotype if early ectoderm 






 Similar to in vitro reports of Kdm6b function within both endodermal and 
ectodermal lineages, investigations using mouse ES cells have implicated Kdm6b as a 
contributor to mesodermal specification (Jiang et al., 2013; Morales Torres et al., 2013; 
Ohtani et al., 2013; Shpargel et al., 2014), T-cell differentiation (Kim et al., 2011; Manna 
et al., 2015), and the differentiation of several different lineages within the cardiovascular 
system (Burgold et al., 2012; Li et al., 2014b; Ohtani et al., 2013). An in vivo assessment 
of Kdm6b function within cardiovascular development was precluded by the early 
lethality (embryonic day 6.5) of Kdm6bKO mice generated by Ohtani et al. (2013). 
Importantly, the early lethality observed in these mice is consistent with the hypothesis 
that Kdm6b has a role during early development; however, this stands in contrast to the 
perinatal lethality reported by others (Li et al., 2014b; Shpargel et al., 2014; Zhang et al., 
2015). Comprehensively, these data provide insights into potential functions of Kdm6b 
during development; however, inconsistencies between in vitro and in vivo data sets cast 
uncertainty over Kdm6b’s role during early development and highlight the need for 
further investigation.  
 
 While there are many well-known benefits of using the mouse as a model for 
development, there are limitations to their utility when studying early developmental 
events. Mice are viviparous and as such, embryos proceed through much of development 
obscured from view within the uterus. Small litter sizes can also render large-scale 
screens intractable. One of the reasons for the ongoing success of zebrafish as a model 
organism is that they are oviparous, allowing direct observation of embryogenesis in its 





adolescence during which observations can be made regarding tissue maintenance and 
homeostasis. Zebrafish can therefore circumvent several experimental limitations 
imposed by the mouse model.  
 
 Generation of genetic mutations in zebrafish have traditionally depended on 
random mutagenesis screens (Mullins et al., 1994), thus confining researchers to a 
forward genetic approach. Until recently, reverse genetic approaches were largely 
performed using morpholino-mediated knockdown, which are less consistent than genetic 
knockdowns and are speculated to be prone to off-target effects (Lawson, 2016). With the 
recent development of techniques such as clustered regularly interspaced short 
palindromic repeats (CRISPR) /Cas9 and transcription activator-like effector nucleases 
(TALENs), the generation of targeted mutations for proper reverse genetic 
experimentation can now be achieved in zebrafish. In applying these techniques, 
researchers have overcome a substantial limitation and drastically increased the utility of 
the model.  
 
 The material presented in Chapter II utilizes the advantages of the zebrafish 
model by capitalizing on contemporary techniques such as CRISPR/Cas9 targeted 
mutagenesis. Using this technology, we describe a novel model for kdm6b-demethylase 
function during development in zebrafish. We show that while not required for early 
cardiogenesis, ohnologous histone demethylases kdm6ba and kdm6bb function 
redundantly to regulate proliferation during late stage cardiac morphogenesis and 





kdm6b ohnologs and support the hypothesis that kdm6b demethylases function primarily 
during later stages of organogenesis. Additionally, our description of morpholino-induced 
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INTRODUCTION 
Covalent histone modifications establish chromatin landscapes that influence gene 
expression programs by promoting active or silenced transcriptional states. Localized 
trimethylation of lysine 27 on histone 3 (H3K27me3) is deposited by Enhancer of zeste 
homolog 1 and 2 (Ezh1 and 2), the catalytic subunits of the Polycomb repressive complex 
2 (PRC2), and is associated with gene silencing (Cao et al., 2002; Margueron and 
Reinberg, 2011; Müller et al., 2002). H3K27me3 marks can be relieved by the lysine-
specific demethylases Kdm6a (Utx) and Kdm6b (Jmjd3) (Cloos et al., 2008; Klose and 
Zhang, 2007; Mosammaparast and Shi, 2010). Therefore, H3K27me3 modifications 





vertebrates, H3K27me3 dynamics are implicated in cell fate specification (Alder et al., 
2010; Dahl et al., 2010; Rugg-Gunn et al., 2010) activation of gene expression programs 
in response to cell signaling or transcription factors (Jiang et al., 2013; Kartikasari et al., 
2013; Ramadoss et al., 2012), and cell reprogramming associated with acquired 
pluripotency (Azuara et al., 2006; Bernstein et al., 2006; Mikkelsen et al., 2007) as well 
as de-differentiation during organ regeneration (Stewart et al., 2009).   
 
In vitro studies using embryonic stem cells (ES cells) suggest Kdm6b enables early cell 
specification of all three germ layers (Burgold et al., 2008; Kartikasari et al., 2013; 
Ohtani et al., 2013; Ohtani et al., 2011). These results predict that Kdm6b is responsible 
for relieving H3K27me3 at fate specifying genes as pluripotent cells adopt distinct cell 
lineage identities (Bernstein et al., 2006; Mikkelsen et al., 2007). However, in vivo tests 
of this model using mouse Kdm6b reverse genetics have yielded conflicting results. Mice 
homozygous for a Kdm6b allele that deletes exons encoding N-terminal regions of the 
protein are peri-implantation lethal at embryonic day 6.5 (E6.5) (Ohtani 2013). In 
contrast, mice homozygous for several independently generated Kdm6b mutant alleles 
that delete the catalytic JmjC domain survive embryogenesis before dying perinatally 
with lung development defects (Li et al., 2014b; Satoh et al., 2010; Shpargel et al., 2014; 
Zhang et al., 2015). The discrepancy in phenotypes between the N-terminal and JmjC-
deletion Kdm6b alleles is unresolved, but may reflect demethylase-independent functions 
of Kdm6b (Miller et al., 2010) retained in truncated protein produced by the JmjC-






Kdm6b-deficient embryos are smaller and edematous (Li et al., 2014b), suggesting that 
Kdm6b contributes to cardiovascular development. In further support, H3K27me3 marks 
are conspicuously lost from key cardiogenic genes during in vitro cardiac differentiation 
of ES cells (Paige et al., 2012; Wamstad et al., 2012)) and PRC2 is required to maintain 
cardiomyocyte identity (Delgado-Olguín et al., 2012; He et al., 2012). Additionally, 
Kdm6b-/- ESCs induced to undergo cardiomyocyte differentiation misexpress many genes 
implicated in early heart development, including decreased levels of the cardiac 
progenitor factors Mesp1, Pdgfra, and Mef2c (Ohtani et al., 2011). Correspondingly, 
Kdm6b-deficient ES cells exhibit reduced ability to form differentiated cardiomyocytes 
and contractile embryoid bodies (EBs). While in vivo mouse and zebrafish studies 
demonstrate Kdm6a contributes to the activation of core cardiac transcription factors 
(Lee et al., 2012; Van Laarhoven et al., 2015; Welstead et al., 2012), the in vivo 
contributions of Kdm6b to cardiovascular development have not been examined.   
 
We pursued in vivo loss-of-function studies in zebrafish to define Kdm6b’s evolutionarily 
conserved contributions to vertebrate development. Due to teleost whole genome 
duplication, the zebrafish genome contains two Kdm6b orthologs, kdm6ba and kdm6bb. 
In such instances of duplicated genes, the “ohnologs” commonly acquire unique 
expression patterns and therefore functions or one “ohnolog” becomes non-functional due 
to relaxed selective pressures (Brunet et al., 2006; Force et al., 1999; Jaillon et al., 2004; 
Lynch and Force, 2000; Woods et al., 2005). While there is no literature describing 





developmental gene programs during fin regeneration (Stewart et al., 2009) and therefore 
was the focus of our initial studies. 
 
Exemplified by CRISPR/Cas9 methodologies, genome editing recently has enabled 
genuine reverse genetics studies in zebrafish (Foley et al., 2009; Hruscha et al., 2013; 
Hwang et al., 2013; Shin et al., 2014). The resulting rapid emergence of targeted alleles 
has uncovered multiple cases of discrepancy between genetic mutant and morpholino-
induced phenotypes, raising substantial concern about the reliability of even well-
controlled zebrafish morpholino studies (Kok et al., 2014; Lawson, 2016). Conversely, 
the historic contributions of morpholino-mediated knockdowns along with their 
versatility and ease of use are cited as justifying their continued use (Blum et al., 2015). 
The phenomenon of genetic compensation in zebrafish further supports this argument 
exemplified by a case in which morpholino-mediated knockdown portrays a more 
complete representation of gene function than the corresponding genetic mutant (Rossi et 
al., 2015).  
 
We generated kdm6bb loss-of-function alleles using CRISPR/Cas9 mutagenesis and 
novel kdm6bb “morphants” given the reported advantages of each loss-of-function 
approach. We found that specific cardiovascular defects produced by morpholino-
mediated knockdown of kdm6bb are not recapitulated in kdm6bb-/- embryos and instead 
originate from spurious off-target effects. Through further genetic loss-of-function 
studies, we show that kdm6bb functions redundantly with kdm6ba, consistent with their 





pleiotropic yet specific organogenesis defects, including a small heart ventricle. This 
phenotype originates from insufficient cell proliferation of both endo- and myocardial 
cells associated with the initiation of cardiac trabeculation at larval hatching. Our data 
provides an example of straightforward non-compensatory redundancy between 
duplicated genes in zebrafish that, together with off-target morpholino effects, can 
explain “mutant” vs. “morphant” phenotype discrepancies. Further, we show that 
Kdm6b’s unique functions (those not shared with Kdm6a) are largely restricted to later 
stages of organ growth and morphogenesis rather than early cell fate specification or 
progenitor cell activity. 
 
RESULTS 
Cardiovascular defects in kdm6bb morphant zebrafish are not recapitulated with a 
CRISPR/Cas9-generated kdm6bb null allele 
To investigate the role of H3K27me3 histone demethylase kdm6bb during zebrafish 
development, we performed loss-of-function experiments targeting the essential catalytic 
JmjC domain (Hong et al., 2007; Xiang et al., 2007) using two parallel approaches. First, 
we generated a mutant allele of kdm6bb using CRISPR/Cas9 targeted mutagenesis. 
Second, we employed antisense morpholinos to target kdm6bb transcript splicing. 
 
CRISPR/Cas9 mutagenesis was used to induce insertion-deletion (indel) mutations near 
the 5’ end of the JmjC-coding domain of kdm6bb. We isolated a germline-transmitted 
allele (kdm6bbb1307, abbreviated kdm6bb- from here forth) with a 40 bp deletion spanning 





predicted to result in a truncated Kdm6bb protein lacking the entire JmjC domain. 
Further, kdm6bb transcript levels were decreased nearly nine fold in homozygous 
kdm6bb-/- animals at 30 hpf due to nonsense mediated decay, as shown by qRT-PCR and 
in situ hybridization (Fig. 1B-D). Surprisingly, kdm6bb-/- fish did not exhibit any overt 
developmental defects and were viable through adulthood (Fig. 1E-H). A recent report 
proposes that unknown genetic compensation mechanisms specifically can obscure gene 
function in genetic mutants (Rossi et al., 2015). Therefore, to determine if the absence of 
developmental phenotypes in kdm6bb-/- animals accurately reflects Kdm6bb’s biological 
roles, we pursued parallel loss-of-function experiments using a traditional morpholino-
mediated knockdown approach. 
Figure 1. Comparative loss-of-function studies of kdm6bb yield conflicting phenotypes.  
(A) Schematic showing binding sites for anti-kdm6bb morpholinos (red bars) and the deleted sequence in 
the kdm6bb mutant allele recovered from CRISPR/Cas9 targeted mutagenesis (red bases). (B-C) In situ 
hybridization on WT and mutant animals at 24 hpf. (D) qRT-PCR using cDNA from 3 separate pools (n = 
10) of kdm6bb-/-  and WT embryos, normalized to rpl18. P-value determined by Student’s two-tailed t-test. 
(E-H) DIC images of kdm6bb-/- and clutch mate control animals. (I-L) Whole mount DIC images of 
kdm6bb morphants. (M-N) Whole mount immunostaining with DIC overlay of morphant embryos. Arrows 
indicate ventricular position. (O-P) Fluorescent imaging of aortic arch arteries in 72 hpf kdm6bb 
morphants. (Q-R) Whole mount immunostaining with DIC overlay of kdm6bb-/- embryos. (S-T) 
Fluorescent imaging of aortic arch arteries in 72 hpf kdm6bb-/- Tg(flk:EGFP) animals. Abbreviations used: 
h, heart; ora, opercular artery; 3, first branchial arch artery; 4, second branchial arch artery; 5, third 











Following guidelines for best practice morpholino use in zebrafish (Eisen and Smith, 
2008), we developed an antisense morpholino “cocktail” approach to target kdm6bb 
transcripts. We targeted the splice junctions of the first three exons within the JmjC 
domain with a previously published morpholino (Mo4) (Stewart et al., 2009) and two 
novel oligos (Mo5 & Mo6) that each prevented the splicing of an adjacent intron (Fig. 1A 
and Fig. S1B). To minimize toxicity or off-target effects, we used a morpholino cocktail 
containing each anti-kdm6bb morpholino at a concentration of 133 µM, which was below 
that where each individual morpholino produced developmental defects (Fig. S1C). 
Kdm6bbMo456 embryos had no overt phenotypes at 24 hours post fertilization (hpf) (Fig. 
1I & 1K), suggesting that the morpholino cocktail did not promote general toxicity or 
aberrant p53 activation (Nasevicius and Ekker, 2000; Robu et al., 2007). By 48 hpf, 
kdm6bbMo456 embryos exhibited abnormal dorsal curvature and yolk sac extension (Fig. 
1J and 1L), often accompanied by cardiac edema and poor blood flow (Movie S1).  
 
To investigate potential cardiovascular defects in kdm6bbMo456 embryos, we performed 
whole-mount anti-GFP immunostaining on morpholino-injected animals carrying the 
Tg(myl7:EGFP) transgene. While 48 hpf kdm6bbMo456 embryos had a normal atrium and 
atrioventricular canal, they exhibited a notably smaller ventricle (Fig. 1M-N). We next 
injected morpholinos into embryos carrying the Tg(kdrl:EGFP) transgenic reporter (Jin et 
al., 2005), which fluorescently labels endothelial cells, to assess vascular network 
development. 72 hpf Kdm6bbMo456; Tg(kdrl:EGFP) larvae had malformed aortic arch 





observed in kdm6bbMo456 zebrafish embryos suggest Kdm6bb has multiple specific roles 
during cardiovascular development. 
 
Contrary to kdm6bbMo456 morphants, kdm6bb-/- larvae did not exhibit an overtly 
diminished ventricle at 48 hpf (Fig 1Q-R) nor malformed aortic arch arteries at 72 hpf 
(Fig 1S-T). The discrepancies between kdm6bb mutant and morpholino-mediated 
phenotypes is reminiscent of inconsistencies observed by other groups that have 
challenged the reliability of morpholino studies (Kok et al., 2014; Law and Sargent, 
2014). Conversely, other reports highlight the potential benefits of antisense morpholinos 
in avoiding maternal contributions, genetic compensation, and sometimes unpredictable 
protein products that can undermine genetic mutant studies (Blum et al., 2015; Rossi et 
al., 2015). Given the widespread ramifications of the morpholino vs. mutant debate, we 
pursued kdm6bb as a model locus to compare the two loss-of-function approaches while 
continuing to characterize kdm6bb’s developmental roles.  
 
Off-target morpholino effects, rather than maternal contributions or genetic 
compensation, explain the phenotypic discrepancy between kdm6bbMo456 and 
kdm6bb-/- zebrafish 
Antisense morpholinos inhibit transcript splicing as well as ribosome binding and can 
therefore affect the translation of both maternally deposited and zygotically produced 
transcripts. As such, maternal contributions can potentially explain why more severe 
phenotypes are observed in morphants vs. homozygous null mutants of the corresponding 





kdm6bb morphants and maternal zygotic (MZ) kdm6bb-deficient (kdm6bbMZ) embryos 
derived from kdm6bb-/- females. Using the Tg(cmlc:DsRed-nuc) reporter to quantify 
cardiomyocytes at 72 hpf (Takeuchi et al., 2011), we found that kdm6bbMo456 embryos 
displayed a reduced number of ventricular but not atrial cardiomyocytes (Fig. 2A-C). In 
contrast, the number of ventricular cardiomyocytes was unchanged in kdm6bbMZ embryos 
(Fig. 2D-F). The depletion of ventricular but not atrial cardiomyocytes in kdm6bbMo456 
embryos suggested a deficiency in second heart field (SHF) cardiac progenitor cells that 
contribute to the ventricle and outflow tract (OFT) (Guner-Ataman et al., 2013; Hami et 
al., 2011; Jahangiri et al., 2016; Zhou et al., 2011). Consistent with this notion, 
immunostaining for Elastin-B (Eln2), an OFT-enriched extracellular matrix protein (Miao 
et al., 2007), revealed that the OFT was completely absent in kdm6bb morphants at 72 
hpf (Fig. 2G-H). Conversely, the OFT of 72 hpf kdm6bbMZ animals was qualitatively 
normal (Fig. 2I-J). Further, kdm6bbMZ adult fish were viable and fertile. Therefore, we 
conclude that the distinct kdm6bb morphant cardiovascular phenotypes impacting SHF-
derived structures are not caused by inhibition of maternally-deposited kdm6bb mRNA. 
Figure 2. Kdm6bb morphant phenotypes originate from off-target effects 
(A-B) Fluorescent cardiomyocyte nuclei at 72 hpf in control and morphant Tg(cmlc2:DsRed-nuc) ; 
Tg(myl7:EGFP-Hras) embryos. (C) Quantification of cardiomyocytes in 72 hpf control and morphant 
embryos. (D-E) Fluorescent cardiomyocyte nuclei at 72 hpf in control and maternal zygotic kdm6bb-/-MZ 
Tg(cmlc2:DsRed-nuc) animals counterstained with CT3. (F) Quantification of cardiomyocytes in 72 hpf 
kdm6bb-/-MZ Tg(cmlc2:DsRed-nuc) embryos. (G-J) CT3 and ELN2 stained whole mounts show outflow 
tract (yellow arrows) in morphant and kdm6bb-/-MZ embryos. White arrows represent an absent OFT. (K) 
qRT-PCR using cDNA generated from 3 separate samples of pooled (n = 10) WT and kdm6bbMZ embryos 
at 30 hpf. P-value determined via the student’s two-tailed t-test. (L-Q) Single morpholino injections into 
both kdm6bb-/- shown by whole mount DIC (L&O), Tg(flk:EGFP) reporter (M&P) and OFT 










We sought to determine if the phenotypic discrepancy between kdm6bbMZ and 
kdm6bbMo456 animals could be attributed to “compensation” by the programmed 
transcriptional activation of functionally related genes (Rossi et al., 2015). Only four 
zebrafish genes have predicted H3K27 demethylase activity (kdm6ba, kdm6bb, kdm6a, 
and kdm6al), enabling us to assay for genetic compensation without performing a whole 
transcriptome analysis. Neither kdm6ba nor the Utx orthologs, kdm6a and kdm6al, were 
transcriptionally up-regulated in 30 hpf kdm6bbMZ embryos as shown by qRT-PCR (Fig. 
2K). Therefore, genetic compensation is unlikely to be occurring in kdm6bb-deficient 
animals, and, as such, cannot explain the phenotypic discrepancy between kdm6bb 
mutant and morphant embryos.  
 
Morpholinos can unpredictably affect off-target transcripts even when producing specific 
phenotypes (Coffman et al., 2004; Ekker and Larson, 2001; Kok et al., 2014; Lawson, 
2016). We injected the kdm6bb morpholino cocktail into kdm6bb-/- embryos and observed 
indistinguishable aortic arch artery and OFT defects in control and kdm6bb-deficient 
embryos (Fig. S2). Most revealingly, these cardiovascular defects persisted despite the 
deletion of Mo5’s target sequence from the genome of kdm6bb-/- animals. Similarly, a 
higher dose of Mo5 alone produced similar aortic arch artery and outflow tract defects to 
kdm6bbMo456 morphants even in the kdm6bb-/- genetic background (Fig. 2L-Q, S3). These 
data conclusively demonstrate that the observed kdm6bb morphant phenotypes are 






Histone demethylases kdm6ba and kdm6bb have non-compensatory redundant 
functions during zebrafish development 
Sea urchin studies show that morpholinos can affect the translation of off-target 
transcripts with partially-overlapping target sequences (Coffman et al., 2004). Our 
morpholinos were designed with broad differences between each target sequence, which 
excludes synergistic activity with respect to common off-target transcripts. However, 
other genes within the kdm6-family possess short stretches matching each of the three 
morpholino target sequences due to the highly conserved JmjC-coding regions. Most 
notably, kdm6ba, the ohnolog of kdm6bb, contains between 9 and 13 contiguous bases 
matching each morpholino target sequence. While the key Mo5 did not appear to disrupt 
splicing of kdm6ba (or kdm6a and kdm6al) transcripts (Fig. S4), we did not have a 
Kdm6ba antibody to assess Mo5’s effects on kdm6ba translation. Therefore, while 
unlikely, we do not exclude the possibility that cardiovascular defects observed in 
kdm6bbMo456 embryos result from the partial loss-of-function of kdm6ba in addition to 
kdm6bb. Further, redundant functions of kdm6ba and kdm6bb may obscure 
developmental phenotypes in kdm6bb-/- fish.  
 
By RNA in situ hybridization studies, we found that kdm6ba and kdm6bb exhibited 
largely overlapping expression patterns during early development, supporting their 
potential redundancy (Fig. 3A-J). While kdm6ba transcripts showed a higher maternal 
contribution (Fig. 3F), both kdm6ba and kdm6bb transcripts were robustly expressed in 
the developing brain (Fig. 3B-C and G-H), otic vesicles (Fig. 3C and H), and the heart 





CRISPR/Cas9 targeted mutagenesis of the coding region for the JmjC domain. We 
isolated an allele (kdm6bab1308 henceforth denoted kdm6ba-) containing a single base 
deletion within exon 14 of kdm6ba (Fig. 3K). This frameshift mutation was predicted to 
result in an early stop codon yielding a truncated Kdm6ba protein lacking the entire JmjC 
domain. Kdm6ba-/- 30 hpf embryos lacking the notable maternal contribution (kdm6baMZ) 
were homozygous viable, fertile, and showed no overt embryonic defects (Fig. 3L-O). 
Kdm6baMZ animals expressed three times less kdm6ba mRNA than wildtype animals 
(Fig. 3P), reflecting nonsense mediated decay and further suggesting kdm6ba loss of 
function. As with kdm6bbMZ animals, qRT-PCR showed that kdm6ba-deficiency did not 
elicit compensatory expression of kdm6bb, kdm6a, or kdm6al transcripts at 30 hpf (Fig. 
3P). These results argue against genetic compensation from an H3K27 demethylase but 
are consistent with the hypothesis that kdm6ba and kdm6bb are functionally redundant. 
Figure 3. Overlapping transcript expression of kdm6b-family genes and generation of a kdm6ba 
mutant allele  
(A-J) Whole mount in-situ hybridization for kdm6bb (A-E) and kdm6ba (F-J). Arrowheads denote cardiac 
expression. Abbreviations used: a, atrium; v, ventricle. (K) Schematic showing the kdm6ba mutant allele 
recovered from CRISPR/Cas9 targeted mutagenesis. Deleted base shown in red. (L-O) DIC images of 
kdm6baMZ embryos at 24 hpf (L and N) and 48 hpf (M and O). (P) qRT-PCR using cDNA generated from 3 
separate samples of pooled (n = 10) WT and kdm6bbMZ embryos at 30 hpf. P-value determined using a 








To determine if the H3K27me3 demethylases kdm6ba and kdm6bb have redundant 
functions, we next generated kdm6ba-/-;kdm6bb-/- double mutant (or kdm6b-deficient) 
animals. While kdm6ba-/-;kdm6bb-/- fish developed normally over the first three days of 
development (Fig. S5), they failed to inflate their swim bladder upon hatching and were 
not viable past 10-12 dpf (Fig. 4A-E). Kdm6b-deficient larvae also consistently exhibited 
cardiac edema (Fig. 4D-D’) and a craniofacial “slack jaw” abnormality in which the jaw 
was unable to close (Fig. 4D-D’). Kdm6ba-/-;kdm6bb+/- animals also failed to develop a 
swim bladder and did not survive to adulthood (Fig. 4C & E). Conversely, kdm6ba+/-
;kdm6bb-/- animals were completely viable with no obvious embryonic defects (Fig. 4B & 
E). Consistent with kdm6ba being expressed at three-fold higher levels than kdm6bb at 30 
hpf (Fig. 4F), this combined dose-dependency suggests that kdm6ba has relatively 







Figure 4. Combined genetic deficiency of kdm6ba and kdm6bb causes pleiotropic larval development 
defects 
(A-D) Whole mount stitched DIC images of clutch mates. (A’ & D’) Zoomed image of A and D 
respectively. (E) Viability table showing the genotype frequencies observed in adult animals derived from a 
kdm6ba+/-;kdm6bb+/- double heterozygous in cross. (F) qRT-PCR of relative levels of kdm6ba and kdm6bb 
transcript in WT fish at 30 hpf. Normalized to rpl18. P-value determined with students two-tailed t-test. 
(G&H) Dorsal view of whole-mount embryos. (I&J) H&E sagittal sections showing swim bladder. (K&L) 
Sagittal whole-mount view of alcian blue staining. (M-P) Flat mount of alcian blue stains showing basihyal 
cartilage. (Q-T) H&Es showing basihyal cartilage in sagittal (Q&R) and coronal (S&T) sections. 
 
A further analysis of 5 dpf kdm6ba-/-;kdm6bb-/- larvae revealed pleiotropic defects. 
Kdm6b-deficient animals exhibited cranial swelling arising between 4 and 5 dpf (Fig. 4G-
H). Hematoxylin and eosin (H&E) staining of paraffin sections confirmed an intact but 
un-inflated swim bladder in kdm6ba-/-;kdm6bb-/- larvae (Fig. 4I-J). As Kdm6b promotes 
endochondral bone formation in mice (Zhang et al., 2015), we performed Alcian Blue 
staining to determine if kdm6b-deficient larvae exhibited abnormal cartilaginous bone. 
While the majority of craniofacial skeletal development was unaffected, kdm6ba-/-
;kdm6bb-/- larvae displayed a truncated basihyal cartilage at 5 dpf and 7 dpf that likely 
accounts for the “slack-jaw” phenotype (Fig. 4K-P). By H&E staining of 7 dpf larvae, we 





fewer but otherwise normally differentiated chondrocytes and retained associated 
ligaments (Fig. 4Q-T). These phenotypes and the larval stage lethality of kdm6ba-/-
;kdm6bb-/- fish is more consistent with those mouse studies suggesting Kdm6b largely 
functions during later stages of organogenesis rather than during early cell lineage 
specification (Burgold et al., 2012; Li et al., 2014b; Satoh et al., 2010; Shpargel et al., 
2014; Zhang et al., 2015). 
 
Kdm6b proteins promote larval stage cell proliferation associated with heart 
ventricle trabeculation 
We continued our analysis of the cardiovascular system of kdm6ba-/-;kdm6bb-/- fish to 
determine if they phenocopied kdm6bbMo456 animals in any respect. Kdm6b-deficient 72 
hpf larvae did not display the characteristic aortic arch artery, outflow tract, or ventricular 
cardiomyocyte defects seen in kdm6bbMo456 animals (Fig. 5A-E). Additionally, severe 
craniofacial defects in morphants at 5 dpf prevented analysis of basihyal cartilage 
development and reflect the capacity of morpholino-induced off-target effects to mask 
the presence of specific loss-of-function phenotypes (Fig. S6A-C).  Given the disparate 
collection of kdm6bb morphant vs. kdm6ba-/-;kdm6bb-/- phenotypes, we conclude that the 
kdm6bbMo456 fails to accurately portray kdm6bb function due to spurious morpholino 
effects acting alone or in combination with kdm6bb transcript knockdown. 
Figure 5. Kdm6ba and kdm6bb  redundantly promote cardiac trabeculation 
(A&C) Fluorescent imaging of aortic arch arteries in 72 hpf kdm6b-deficient and control Tg(flk:EGFP) 
animals. (B&D) Fluorescent cardiomyocyte nuclei at 72 hpf in control and maternal zygotic kdm6bb-
deficient and control Tg(cmlc2:DsRed-nuc) animals counterstained with CT3. (E) Quantification of 
cardiomyocytes at 72 hpf. (F-G) DIC images of the OFT and ventricle of control and kdm6b-deficient 
embryos at 5 dpf. (H-I) Fluorescent cardiomyocyte nuclei at 5 dpf in control and maternal zygotic kdm6bb-
deficient and control Tg(cmlc2:DsRed-nuc) animals counterstained with CT3. (J-M) H&E stained sagittal 
sections of 5 and 7 dpf embryos with solid black line indicating trabeculae and dashed yellow line 
indicating AVC valves. (N-O) Quantification of area and trabeculation index. P-value determined by a 










The absence of early cardiovascular or other phenotypes in kdm6ba-/-;kdm6bb-/- embryos 
suggests that kdm6b demethylases are not required for early lineage specification events, 
arguing against models derived from in vitro experiments (Burgold et al., 2008; 
Kartikasari et al., 2013; Ohtani et al., 2011; Ohtani et al., 2013). While the lethality of 
kdm6ba-/-;kdm6bb-/- animals precluded us from eliminating maternal contributions of both 
transcripts, only kdm6ba transcripts were present prior to zygotic genome activation. To 
achieve maximum kdm6b depletion in the early embryo with respect to both maternal and 
zygotic contributions, we crossed kdm6ba-/-;kdm6bb+/+ females to kdm6ba+/-;kdm6bb-/- 
males. Kdm6baMZ;kdm6bb+/- progeny from this cross were phenotypically 
indistinguishable from kdm6ba-/-;kdm6bb+/- animals, including lacking the severe edema 
and slack-jaw phenotype of kdm6ba-/-;kdm6bb-/- double mutants (Fig. S6D-F). We 
conclude that kdm6b demethylases do not have unique early embryogenesis roles 
necessitating maternally contributed transcripts or protein. 
 
Despite the lack of embryonic cardiovascular phenotypes, the presence of cardiac edema 
in 5 dpf kdm6ba-/-;kdm6bb-/- larvae implied a role for kdm6b demethylases in 
cardiogenesis. Live imaging revealed the hearts of kdm6b-deficient 5 dpf larvae produced 
unidirectional and steady blood flow, consistent with their normal-appearing OFT and 
OFT valve (Movie S2, Fig. 5F-G). However, kdm6ba-/-;kdm6bb-/- larvae had a smaller 
and more spherically-shaped ventricle, which was also apparent by whole mount staining 
for cardiac troponin (CT3) and DsRed in a Tg(cmlc:DsRed-nuc) background  (Fig. 5H-I). 
To further characterize ventricle morphology in kdm6b-deficient animals, we analyzed 





a smaller and more rounded ventricle with dramatically reduced number and size of 
trabecular projections that normally form on the outer curvature of the zebrafish ventricle 
between 3 and 4 dpf (Liu et al., 2010) (Fig. 5J-K). The OFT, atria, and atrioventricular 
canal (AVC) valves were notably unaffected. The specific trabeculation defect was 
further apparent at 7 dpf (Fig. 5L-M). Quantitatively, kdm6b-deficient larvae first showed 
diminished trabeculation at 5 dpf followed by reduced ventricular muscle at 7 dpf (Fig. 
5N, O, Fig. S7). We conclude that kdm6ba and kdm6bb share a specific role in promoting 
early stages of zebrafish cardiac trabeculation. 
 
By immunostaining sectioned larvae, we found that myosin heavy chain (MHC, 
recognized using the pan-myocardial MF20 antibody) and S46 (atrial cardiomyocyte-
specific) were expressed normally in 5 dpf kdm6ba-/-;kdm6bb-/- larval hearts (Fig. 6A-D’). 
Therefore, the diminished cardiac trabeculation in kdm6b-deficient larvae did not reflect 
an altered chamber identity. CT3 antibody staining further confirmed that ventricular 
cardiomyocytes of kdm6-deficient larvae were differentiated and formed myofibrils (Fig. 
6B-B’ and D-D’). Finally, we used the Tg(flk1:EGFP) reporter line and anti-GFP 
staining to determine that the endocardium of kdm6b-deficient embryos was present and 
maintained its epithelial organization (Fig. 6E’-F’). Collectively, we conclude that 
Kdm6b is not required for the specification or differentiation of endocardial and 
myocardial cells and therefore that the trabeculation defects in kdm6b-deficient larvae 






Figure 6. Kdm6b proteins enable coordinated endocardial and myocardial proliferation associated 
with early larval ventricle maturation. 
(A-C) Immunofluorescence images of 5 dpf control and kdm6b-deficient Tg(flk:EGFP) embryos stained 
with anti-MF20 and anti-GFP antibodies. (B&D) anti-CT3 antibody staining showing superficial sections 
of the heart at 5 dpf. (E-F’) Immunofluorescence images of 5 dpf sections of control and kdm6b-defieient 
Tg(flk:EGFP) embryos stained with wheat germ agglutinin (WGA), anti-GFP, and anti-PCNA antibodies. 
Yellow boxed indicate zoomed regions in E’&F’, arrows indicate PCNA-positive endocardial cells and 
arrowheads indicate PCNA-positive myocardial cells. (G) Quantification of PCNA positive cells in control 
and kdm6b-deficient embryos at 5 dpf. P-value determined via students two-tailed t-test. (H-I) EdU 
labeling along with anti-MF20 immunofluorescence in 5 dpf control and kdm6b-deficient embryos.  
 
Myocardial proliferation around the time of larval hatching is required for the initiation 
of trabeculation in zebrafish (Liu et al., 2010). To determine if cardiac proliferation was 





nuclear antigen (PCNA), a marker of cycling cells (Fig. 6E-F’”). Kdm6b-deficient 
animals displayed a near 50% reduction of both PCNA positive endocardial and 
myocardial cells at 5 dpf (Fig. 6G). This striking decrease in proliferative ventricular 
cells in kdm6ba-/-;kdm6bb-/- larvae was also apparent using 5-ethynyl-2-deoxyuridine 
(EdU) incorporation assays to monitor cells that passed through S-phase between 4 and 5 
dpf (Fig. 6H-J). In contrast, the normal number of cardiomyocytes in 72 hpf kdm6ba-/-
;kdm6bb-/- fish (Fig. 5B and D) showed that embryonic cardiac proliferation was not 
disrupted in the absence of Kdm6b. We conclude that kdm6bb and kdm6ba redundantly 
promote trabecular outgrowth by enabling the coordinated endo- and myocardial 
proliferation that accompanies the larval stage initiation of trabeculation.  
 
Kdm6b directs global H3K27me3 demethylation in cardiomyocytes coupled with the 
initiation of myocardial trabeculation 
Kdm6b’s role in trabecular proliferation presumably involves modifying chromatin 
landscapes to support gene activation to enable cell cycle entry and/or prevent cellular 
quiescence. To explore if Kdm6b regulates global changes in H3K27me3 levels during 
heart ventricle maturation, we immunostained sections of 3 dpf control and kdm6ba-/-
;kdm6bb-/- larvae with anti-H3K27me3 antibodies. Strikingly, H3K27me3 levels varied 
widely between different cell types. Endocardial cells consistently showed very low 
H3K27me3 levels relative to the myocardium (Fig. 7A-C’). Myocardial cells located on 
the outer ventricular surface consistently had the highest H3K27me3 signal with more 
modest levels in myocardial cells undergoing trabeculation adjacent to the ventricular 





many myocardial but not endocardial cells (Fig. 7D-F’). This myocardial-specific role of 
Kdm6b in moderating cell-wide levels of H3K27me3 was consistent with normal 
amounts of global H3K27me3 seen by Western blotting 5 dpf whole kdm6ba-/-;kdm6bb-/- 
larval lysates (Fig. 7G). We conclude that H3K27me3 levels are dynamically regulated in 
a global in addition to locus- or even nucleosome-specific manner during cardiac 
development. Further, Kdm6b broadly removes H3K27me3 marks on nucleosomes to 
temper the overall H3K27me3 load in trabeculating myocardial cells and support their 
cell cycle entry. 
 
Figure 7. H3K27me3 is retained in kdm6ba-/-;kdm6bb-/-  trabeculating cardiomyocytes  
(A-C’) Immunofluorescence images of 3 dpf control Tg(flk:EGFP) embryos stained with anti-MF20, anti-
GFP, and anti-H3K27me3 antibodies (D-F’) Immunofluorescence images of 3 dpf kdm6b-deficient 
Tg(flk:EGFP) stained with anti-MF20, anti-GFP, and anti-H3K27me3 antibodies. (G) Western blot of 
single animal lysates at 5 dpf.  
 
DISCUSSION 
Our investigation of histone demethylases kdm6ba and kdm6bb during zebrafish 





morpholino” reverse genetic analysis of a previously unstudied zebrafish gene family that 
reinforces the need to carefully control morpholino studies to avoid making conclusions 
based on spurious yet tissue-specific phenotypes. Further, we show how duplicated 
orthologous genes with retained overlapping expression can obscure loss-of-function 
phenotypes due to simple non-compensatory genetic redundancy. Second, we show that 
Kdm6b-family demethylases have pleiotropic roles during larval organ development 
rather than during embryonic cell specification or the establishment of initial organ 
“frameworks”. Most notably, Kdm6b demethylases specifically contribute to 
cardiogenesis by supporting augmented cellular proliferation associated with the 
initiation of ventricular trabeculation during larval metamorphosis. Heightened global 
H3K27me3 levels in trabeculating cardiomyocytes of kdm6b-deficient fish suggests that 
Kdm6b has a widespread role reversing H3K27me3 repressive marks to support 
cardiomyocyte cell cycle entry. 
 
Kdm6b comparative reverse genetic studies provide an example of off-target 
morpholino effects and non-compensatory redundancy between duplicated genes 
Recent reports using zebrafish have highlighted cases of phenotypic discrepancy between 
genetic mutants and antisense mediated morphants (Kok et al., 2014; Law and Sargent, 
2014; Rossi et al., 2015). The advent of rapid genome editing methods enabled by 
CRISPR/Cas9 has led to many more anecdotal examples that are widely discussed and 
debated informally in the field. Ultimately, we conclude that the distinct embryonic 
cardiovascular defects we observed in our kdm6bb morphants largely result from off-





lack of similar phenotypes upon kdm6bb genetic deficiency including maternal 
contributions, compensation by increased expression of other H3K27me3 demethylases, 
or inadvertent morpholino targeting of the ohnologous kdm6ba transcript.  Most 
strikingly, kdm6ba-/-;kdm6bb-/- double mutant animals have largely distinct pleiotropic 
phenotypes from those observed in kdm6bbMo456, animals. Further, a single kdm6bb 
morpholino produces identical development defects in kdm6bb-/- zebrafish that lack the 
target sequence from their genomes.  
 
While our kdm6bb morphants had the potential to be highly misleading, we hesitate to 
conclude the phenotypes entirely misrepresent Kdm6bb function. Clearly, the 
morpholinos effectively knocked down kdm6bb transcripts. Therefore, the phenotypes 
could represent a synergistic effect between kdm6bb loss-of-function and either general 
or unknown specific off-target effects of the morpholinos. A similar “synthetic” 
phenotype could explain the incongruous egfl7 morpholino/mutant phenotypes with or 
without a programmed compensatory mechanism (Rossi et al., 2015). Further, our 
kdm6bb- and/or kdm6ba- alleles could provide some residual protein activity in spite of 
the considerable nonsense mediated decay and the expected complete loss of JmjC 
catalytic domains, particularly if hypothetical truncated products unexpectedly retained 
non-demethylase dependent activity (Miller et al., 2010; Shpargel et al., 2014). 
Therefore, instances of partial phenocopy may blur the line between off-target and cite-
specific phenotypes and demonstrate how cautious morphant studies can empower initial 






Nevertheless, our results reinforce the value of using genetic mutants to confirm 
experimental results obtained through morpholino-mediated knockdown studies. This is 
especially true when, as in our case, there is limited a priori expectation of the “true”, if 
any, loss-of-function phenotype and the inclination becomes to use excess or additional 
morpholinos until a specific defect is uncovered. Therefore, our work supports existing 
guidelines that rescue experiments are essential to support claims of morpholino 
specificity (Eisen and Smith, 2008). Of note, we were unable to rescue the kdm6bbMo456 
morphants by co-injected kdm6bb mRNA (negative data not shown). Unfortunately, 
however, rescue experiments are not always feasible with highly dose-sensitive 
transcripts or those with complex expression patterns. Finally, even “successful” rescue 
experiments can lead to specious conclusions (Law and Sargent, 2014). Given the ease of 
zebrafish targeted mutagenesis afforded by CRISPR/Cas9, including multiplex targeting 
and F0 screening (Jao et al., 2013) and efficient homologous recombination (Hoshijima et 
al., 2016), we suggest inherently more rigorous genome editing approaches should be 
used whenever possible for zebrafish gene function studies. 
 
Our results also are fully consistent with the proposal that the lack of phenotypes being 
observed in homozygous mutant zebrafish can be attributed to a high degree of 
redundancy built into the zebrafish genome (Lawson, 2016). Zebrafish, having undergone 
a whole genome duplication event, may be more buffered against the effects of a single 
gene mutation than other vertebrate models. Our combined genetic analysis of kdm6bb 
and kdm6ba provides a clear example of how redundant functions between ohnologous 





gene mutation. We suggest this possibility be thoroughly examined for other ohnologous 
gene pairs, especially when expression patterns largely overlap. 
 
Histone demethylases kdm6ba and kdm6bb share likely conserved roles in vertebrate 
organ maturation 
Despite kdm6ba and kdm6bb redundancy and largely similar expression patterns, kdm6ba 
shows increased maternal deposition and 3-fold higher levels of expression at 30 hpf, 
suggesting it exerts a greater influence over development. In support, kdm6ba+/-;kdm6bb-
/- animals are completely viable while kdm6ba-/-;kdm6bb+/- animals do not survive past 
larval stages. The reduced expression and maternal deposition of kdm6bb is likely the 
result of accumulated loss-of-function mutations within its respective regulatory regions 
(Bailey et al., 1978; Li, 1980; Takahata and Maruyama, 1979; Watterson, 1983). 
However, given kdm6bb has not have become completely silenced, a competitive 
advantage, at least outside a laboratory setting, apparently is conferred by retaining both 
kdm6ba and kdm6bb.  
 
Independently developed Kdm6b presumptive null alleles in mice are either pre-
implantation (Ohtani et al., 2013) or perinatal (Burgold et al., 2012; Li et al., 2014b; 
Satoh et al., 2010; Shpargel et al., 2014; Zhang et al., 2015) lethal. Our studies are 
consistent with the latter publications and suggest that Kdm6b proteins primarily 
contribute to organ maturation rather than early cell fate specification, in contrast to some 
predictions (Kartikasari et al., 2013; Ohtani et al., 2011). These roles are likely 





zebrafish are reminiscent of those reported in mice. For example, kdm6ba-/-;kdm6bb-/- fish 
display stunted craniofacial bone formation and Kdm6b-deficient mice develop skeletal 
dwarfism during early stages of bone development (Zhang et al., 2015). However, a 
further characterization is necessary to determine if Kdmb6 proteins have restricted roles 
in certain bones (e.g. the notably truncated basihyal cartilage in kdm6b double mutants) 
or widely contribute to bone formation, as seen in mice. Similarly, the swim bladder 
defects we observed in our kdm6b-deficient zebrafish may parallel lung structure and 
respiration defects in Kdm6b KO mice (Li et al., 2014b) given the evolutionary homology 
between the teleost swim bladder and lungs of terrestrial vertebrates (Perry et al., 2001; 
Winata et al., 2009).  
 
Kdm6b-deficient zebrafish complete the initial stages of cardiac development, forming 
discrete heart chambers, an outflow tract, and valves. As such, earlier events including 
the generation and expansion of cardiac progenitors, specification and differentiation of 
endocardial and myocardial cells, and initial heart tube extension and looping do not 
require Kdm6b. This conclusion controverts reported roles of Kdm6b in mesodermal and 
cardiovascular differentiation derived from embryonic stem cell studies (Ohtani et al., 
2011). Importantly, our zebrafish studies are consistent with the preponderance of Kdm6b 
loss-of-function mouse models that survive to late fetal stages, indicating the overt 
cardiogenesis is not substantially Kdm6b-dependent.   
 
While our study shows that combined kdm6ba and kdm6bb are not required for early 





(Utx) genes. While mouse genetic studies show that Kdm6a has essential developmental 
functions, including in mesoderm lineage differentiation and cardiogenesis (Lee et al., 
2012; Shpargel et al., 2012; Wang et al., 2012; Welstead et al., 2012). Kdm6b and Kdm6a 
are proposed to function redundantly during thymocyte differentiation (Manna et al., 
2015). While both have H3K27-demethylase activity and can associate with conserved 
components of chromatin organizers such as Brg1 (Miller et al., 2010), the distinct 
phenotypes observed in Kdm6a and Kdm6b mouse models along with conflicting reports 
of shared functional interactions with other chromatin modifiers such as the H3K4 
methyltransferase MLL2 (De Santa et al., 2007; Issaeva et al., 2007; Williams et al., 
2014), suggest only a partial redundancy that is context dependent. Zebrafish contain two 
Kdm6a orthologs, kdm6a and kdm6al. While neither gene has been explored genetically, 
morpholino studies implicate both kdm6a and kdm6al in hox-dependent body plan 
patterning, craniofacial cartilage development, heart looping, and brain morphology (Lan 
et al., 2007; Van Laarhoven et al., 2015). However, given concerns about morpholino 
specificity, reverse genetic studies examining kdm6a and kdm6al individually, together, 
and combined with our kdm6b alleles are necessary to validate and extend these studies. 
 
Histone demethylases kdm6ba and kdm6bb promote proliferation coupled with the 
initiation of cardiac trabeculation 
Trabeculation of the zebrafish ventricle initiates around 72 hpf with the specification of a 
small number of trabeculating cardiomyocytes that separate from the otherwise single 
cell-thick outer myocardial layer (Gupta and Poss, 2012; Han et al., 2016; Liu et al., 





clonally expand during early larval stages to form extensive ridge-like cardiac trabeculae 
that protrude into the ventricular cavity. The initial phase of trabeculation driven by 
neuregulin/ErbB2 signaling (Han et al., 2016; Liu et al., 2010; Peshkovsky et al., 2011) 
does not depend on Kdm6b as we saw that small groups of two cell layer thick 
myocardium still form in kdm6b-deficient fish. Instead, Kdm6b is required for the 
subsequent boost of proliferation at larval hatching (around 96 hpf) seen in trabeculating 
myocardial cells (Gupta and Poss, 2012; Han et al., 2016; Liu et al., 2010) as well as 
adjacent endocardium that concomitantly expands to enshroud the forming trabeculae.  
 
Our H3K27me3 immunostaining studies suggest Kdm6b generally relaxes the repressive 
epigenetic state of trabeculating cardiomyocytes to enable their transcriptional response 
to growth-promoting mitogens rather than activating a specific subset of genes that drive 
cell cycle entry. H3K27me3 are notably lower in both endocardial cells and trabeculating 
myocardial cells compared to the outer wall cardiomyocytes that forms a thin, 
incompletely differentiated “primordial” layer retained through juvenile stages of heart 
development (Gupta and Poss, 2012; Han et al., 2016). In contrast, high H3K27me3 
levels are maintained in trabeculating cardiomyocytes lacking Kdm6b. We propose 
Kdm6b activation, possibly transcriptionally as seen during fin regeneration and immune 
responses (Manna et al., 2015; Stewart et al., 2009) during specification of trabeculation 
cardiomyocytes globally removes repressive H3K27me3 marks that otherwise restrain 
cardiomyocytes from responding to mitogenic signals. As endocardial H3K27me3 levels 
are very low in both wildtype and kdm6b-deficient fish, the endocardial proliferation 





interplay between ventricular endocardium and myocardium that coordinates these 
neighboring cells’ activities during trabeculation (Samsa et al., 2013). 
 
As an alternative to a global H3K27me3 dynamics model, Kdm6b may provide an 
“epigenetic”-reprogramming component of transcriptional switches acting at a discrete 
set of specific target genes. Of potential relevance, the Kdm6b-cooperating BAF 
chromatin remodeling complex (Miller et al., 2010) enables trabeculation in mice by 
repressing endocardial transcription of the trabeculation-suppressing Adamts1 matrix 
protease (Stankunas et al., 2008).  A further possibility is that Kdm6b acts in both 
myocardial and endocardial cells to integrate a systemic signal that widely coordinates 
organ maturation events coupled to larval metamorphosis. Thyroid hormone is one 
immediate candidate that is upregulated upon hatching (Chang et al., 2012) and is a 
known cardiomyocyte mitogen in mammals (Chattergoon et al., 2012; Kenessey and 
Ojamaa, 2006; Li et al., 2014a). Distinguishing between each of these possibilities awaits 
mosaic studies or cell type-specific targeting of kdm6b genes. Regardless, the seemingly 
isolated cardiac developmental role of Kdm6b in promoting cardiomyocyte proliferation 
establish these histone demethylases and downstream target genes as candidate genes for 
congenital heart defects of the ventricle, including hypoplastic left ventricle syndrome. 
 
The recognition that differentiated cardiomyocytes can re-acquire robust proliferative 
ability during heart regeneration in both zebrafish and mice (Jopling et al., 2010; Porrello 
et al., 2011; Poss et al., 2002) and that humans retain some proliferative capacity of 





2016) has focused efforts on understanding these mechanisms to recapitulate them for 
injury repair, notably for congestive heart failure. The role of  Kdm6b histone 
demethylases in developmentally timed cardiomyocyte (but not cardiac progenitor) 
proliferation suggests the reversal of epigenetic H3K27me3 silencing marks may be 
essential aspect of innate heart regeneration and a promising path to augment 
therapeutically delivered cardiomyocytes for heart disease.   
 
MATERIALS AND METHODS 
Zebrafish 
The University of Oregon Institutional Animal Care and Use Committee (IACUC) 
approved and monitored all zebrafish procedures following the guidelines and 
recommendations outlined by the Guide for the Care and Use of Laboratory Animals 
(National Academic Press). The following established lines were used in this study: 
Tg(cmlc2:dsRedExpress-nuc) (Takeuchi et al., 2011), Tg(myl7:EGFP-Hras)s883 (Chi et 
al., 2008), Tg(kdrl:EGFP) (Jin et al., 2005). 
 
CRISPR-Cas9 generation of mutant alleles  
CRISPR-Cas9-mediated mutagenesis was used to generate targeted deletions within the 
putative Jmjc domains of both kdm6ba and kdm6bb. Guide RNAs were generated 
following methods adapted from (Bassett et al., 2013). Guide oligonucleotide sequences 
were obtained from Integrated DNA Technologies: 5’-AATTAATACGACTCACTATA-
NNNNNNNNNNNNNNNNNNNN-GTTTTAGAGCTAGAAATAGC-3’, with a T7 





guide RNA targeting sequences for kdm6ba and kdm6bb were 5’-
GCTTAGCATATTCCCACTGG-3’ and 5’-CAGGTGGAAGGC-GCAGTTGC-3’ , 
respectively. Guide oligonucleotides were annealed to a generic gRNA scaffold (5’-
GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACT-
AGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC-3’) and extended using 
Phusion polymerase (New England Biolabs) followed by column-based purification.  
 
In vitro transcription of gRNAs was performed using the Megascript T7 Transcription Kit 
(Thermo Fisher) and purified via RNA Clean & Concentrator column (ZYMO Research). 
Cas9 mRNA was in vitro transcribed from Addgene plasmid 46757:pT3TS-nCas9n (Jao 
et al., 2013) using the T3 mMessage mMachine kit (Ambion). Cas9 mRNA and gRNA 
were combined and diluted to a final concentration of 100 ng/µl in Danieau’s buffer and 
phenol red. We injected 1-3 nl of the Cas9/gRNA mix into the developing embryo at the 
one-cell stage. Fish raised from injected embryos (see below) were screened for 
mutations by amplicon sequencing (Sequetech). Founders carrying isolated mutant alleles 
were outcrossed to wildtype fish to isolate stable germline transmitting lines used for 
subsequent crosses and phenotypic analyses. 
 
Morpholino microinjections 
Morpholinos (Gene Tools) were injected into single-cell embryos at the indicated 
concentrations and in volumes of 2-3 nl.  
Mo 4: 5’-CCCCCTATTGTCAGACTTACCATTT-3’ 





Mo 6: 5’-TCTGATCTAAAACATACTTTTCACA-3’ 
Control Mo: 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
 
Genotyping kdm6ba and kdm6bb mutant alleles 
The kdm6ba allele was assessed by PCR using primers 5’-
TGGCACAAACATTGACCTGT-3’ and 5’-CATCATGGACAGCAAACCAC-3’ 
followed by restriction digest with NcoI (NEB). The kdm6bb mutant allele was assessed 
by PCR using primers 5’-CTCAAAGCAGAAAGCTGTTGG-3’ and 5’-
GTGTGGCCAACATGACTCAG-3’.  
 
In situ hybridization 
In situ hybridizations were performed as described by Thisse and Thisse (Thisse and 
Thisse, 2008b). Stained embryos were dehydrated into 100% methanol and stored at -
20°C for overnight. Embryos were then rehydrated and allowed to equilibrate in 100% 
glycerol at 4°C. Embryos were imaged using Rottermann contrast optics on a Leica 
M165 FC stereomicroscope. In situ hybridization probes were synthesized from PCRII-
based plasmids (Life Technologies) containing a cloned cDNA amplicon. PCR products 
were obtained from pooled samples of embryonic zebrafish cDNA using the following 
primers: kdm6bb 5’-CCACTTGACCAACTGCCTTGCAAAAC-3’, 5’-
CTGAAAACACACTCCGAGAGGTATCGC-3’; kdm6ba 5’-
TGGCACAAACATTGACCTGT-3’, 5’- GTGTGAGGGAAAGGGATGAG-3’. 
Plasmids were linearized by digestion with NotI and BamHI respectively. Digoxigenin-





or T7 (for kdm6ba probe). DIG-labeled probes were DNase treated prior to LiCl 
precipitation and resuspension in RNase/DNase free water.  
 
Whole mount immunofluorescence and imaging 
Immunostaining for GFP was performed as previously described (Akerberg et al., 2014). 
Staining for CT3 (Developmental Studies Hybridoma Bank), Eln2 (generous gift from 
the Burns lab), dsRed (Clontech) and S46 (Developmental Studies Hybridoma Bank) was 
performed using a protocol adapted from Zhou et al. (Zhou et al., 2011). Embryonic 
hearts were arrested in diastole with 0.5M KCl and fixed overnight at 4°C in phosphate-
buffered saline (PBS) containing 4% paraformaldehyde. The following day, embryos 
were washed in PBS and dehydrated through a methanol series. Embryos in 100% 
methanol were stored at -20°C for at least 24 hours prior to rehydration into PBS 
containing 0.1% Tween-20 (PBST). Embryos were then blocked with PBS containing 1% 
BSA, 1% Triton X-100, 0.1% DMSO for four hours. Embryos were incubated with 
primary antibodies diluted in block solution for 4-5 hours at room temperature with 
gentle agitation followed by three 20’ washes in PBS containing 0.5% Triton X-100 
(PB0.5X). Alexa-conjugated secondary antibodies (Invitrogen) were diluted 1:1000 in 
PB0.5X and incubated with embryos for 2-3 hours at room temperature with gentle 
agitation. Lastly, embryos were washed and stored in TBST (20 mM Tris pH 7.5, 150 
mM NaCl, 0.5% Triton X-100). Primary antibodies CT3, Eln2, dsRed, and S46 were 
used at dilutions of 1:500, 1:1000, 1:500, and 1:250 respectively. Immunostained 
embryos, as well as transgenic embryos with native fluorescence, were mounted in low 





Ti inverted fluorescence microscope, or a Leica SD6000 spinning disk confocal. 10x DIC 
images were taken using a Nikon Eclipse Ti inverted microscope and stitched together 
using NIS Elements Advanced Research (Ar) software.  
 
Live imaging 
Embryos at the desires stage were anesthetized in Tricaine (Western Chemical) and 
immobilized in 0.75% LMP agarose in embryo media (EM). Embryos were imaged on a 
glass bottom FluoroDish (World Precision Instruments) using a Nikon Eclipse Ti 
inverted microscope with Hamamatsu C11440 Orca-Flash2.8 camera.  
 
Quantification 
Cell quantification: Cardiomyocyte quantification was performed on Tg(myl7:dsRed-
nuc) transgenic embryos that were fixed overnight in PBS and 4% paraformaldehyde. 
Embryos were then immediately stained for dsRed and CT3 following the above 
protocol. Embryos were then mounted in low melt agarose and their heads removed to 
provide an unobstructed view of the heart. Mounted embryos were imaged with a Leica 
SD6000 spinning disk confocal. Image stacks were processed and analyzed using the 
ImageJ (NIH) software package.  
Tissue quantification: Area measurements of trabeculated muscle located between OFT 
and the atrioventricular canal (AVC) were made using ImageJ measurement tools. 
Trabeculation index values were obtained by measuring the perimeter of the interior 
(trabecular) and exterior of the ventricle (ImageJ) and assigning a normalized value based 







Alcian Blue staining was performed as previously described (Walker and Kimmel, 2007), 
and imaged with either the Leica M165 FC stereomicroscope (whole mount) or Leica 
upright fluorescent microscope (flat mount). 
 
Histological sectioning and immunostaining  
Paraffin sections were processed following procedures developed for dissected mouse 
hearts (Akerberg et al., 2015). Hematoxylin and eosin staining on paraffin sections was 
performed using conventional reagents and methodology (Ricca Chemical Company). 
For immunostaining paraffin sections, slides were de-paraffinized using Xylenes and 
rehydrated into distilled water using a series of graded ethanol washes. Antigens were 
retrieved by either 1) pressure-cooking for 10’ in 1 mM EDTA and 0.1% Tween-20 
(CT3, PCNA, MF20, EGFP, and DsRed antibodies) or 2) 10’ incubation in 0.25% trypsin 
solution (H3K27me3 antibody). Slides were blocked for 1 hour in either milk (10% dried 
milk, 1x PBS, 0.1% Tween-20) or 10% NGS in PBS (for H3k27me3). Primary antibodies 
were diluted 1:500 (or 1:50 for anti-MF20) in their respective block solution and 
incubated overnight at 4°C. Slides were then washed 5 x 10’ in PBST (1x PBS with 0.1% 
Tween-20). Slides were then incubated with Alexa-conjugated secondary antibodies 
diluted 1:1000 in block solution for 1 hr. Slides were then washed 3 x 10’ in PBST. To 
label nuclei, slides were submerged 5’ in Hoechst diluted 1:5000 in PBST. Slides were 





Histological slides were imaged with a Leica upright fluorescent microscope or an 
Olympus Fluoview FV1000 BX61 confocal microscope.  
 
5-ethynl-2-deoxyuridine labeling 
Fish were incubated with EdU (Life Tech) at a concentration of 0.1 mg/ml in embryo 
media for 12-15 hours prior to harvest at 5 dpf. Embryos were then harvested and 
processed into paraffin sections as described above. EdU Click-It reactions (Life Tech) 
were performed prior to antibody staining and kept in the dark until imaging.  
 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) 
cDNA was synthesized using SuperScript III (Life Technologies) with Trizol-isolated 
RNA harvested from pooled embryos (5-10 embryos per pool). qRT-PCR was performed 
using KAPA SYBR FAST qPCR master mix reagents (Kapa Biosystems). Relative 
mRNA expression was normalized using rpl18 to calculate ΔCTs (threshold cycles). 
Transcript levels were compared using a ΔΔCT approach and two-tailed Student’s t-tests 
to determine significance. qPCR primer sequences: kdm6bb 5’-
GCATGGCGTGGACTATCTG-3’, 5’-CGTGAATCATAGGGACGATTG-3’; kdm6ba 
5’-GCCCAAACCTCTCCAATGTA-3’, 5’-GTGTGAGGGAAAGGGATGAG-3’; 
kdm6a 5’-ACATAAACATTGGCCCTGGA-3’, 5’-GCCACCAAGATCCCATTAGA-3’;  
kdm6al 5’-CACAACAACTTCTGCGCTGT-3’, 5’-CCTCGTACAGGTCCTCCAGA-3’; 







BRIDGE TO CHAPTER III  
The work in Chapter II demonstrates that Kdm6b demethylases are required for late stage 
cardiac development in zebrafish. These results provide valuable insights into the general 
biological significance of H3K27 demethylases and solidify the zebrafish model as a 
viable platform for further epigenetic investigation. Beyond development, our model 
provides a tool with which to probe Kdm6b’s potential involvement in adult tissue 
regeneration. Specifically, the requirement of Kdm6b demethylases for cardiac 
maturation and proliferation lends credence to the hypothesis that they may also be 
involved in cardiac regeneration. The lethality of kdm6b-deficient animals, however, 
prevents the use of these tools for immediate in vivo assessment of Kdm6b function 
during regeneration. In Chapter III, I describe the creation and utility of novel transgenic 
tools for spatiotemporal control of transgene expression in both embryonic and adult 
zebrafish. While the intent was to utilize these tools to achieve RNAi-mediated 
knockdown of Kdm6b-demethylases in the adult zebrafish, this aspect of the project did 
not prove fruitful. However, the novel transgenic system I detail in Chapter III provides 
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BACKGROUND 
Research using transgenic zebrafish lines has greatly contributed to our understanding of 
vertebrate biology. Transgenic zebrafish are used widely for both gain and loss of 
function experiments as well as a means to track specific cell populations. All such 
studies require careful consideration regarding the location, timing, and levels of 
transgene expression. For instance, although constitutive ubiquitous promoters generally 
produce high levels of transgene expression and generate robust phenotypes, they do not 
differentiate cell-type specificity or the timing of gene function. To overcome these 





cell lineages and tissue types. Temporal control of transgene expression further allows 
the determination of windows during which a gene functions, a feature particularly useful 
for developmental biology research. Additionally, multiple roles for a gene during 
development can be distinguished by timing the induction of an appropriate transgene. 
Temporal control of transgene expression in zebrafish is typically achieved using heat-
shock sensitive promoters (Halloran et al., 2000), although small molecule-controlled 
inducible promoters also can control the timing and tune levels of transgene expression 
(Knopf et al., 2010).  
 
One elegant method for transgene expression in metazoans uses the Gal4/UAS two 
component transcriptional activation switch from Saccharomyces cerevisiae (Fischer et 
al., 1988; Sadowski et al., 1988). Gal4 is a transcription factor that functions in yeast 
galactose metabolism (Laughon and Gesteland, 1984) and binds to a unique DNA 
sequence found between the GAL1 and GAL10 genes (Giniger et al., 1985). A version of 
this sequence is now commonly referred to as a UAS (for Upstream Activating 
Sequence). A discrete DNA-binding domain (DBD) of Gal4 is both necessary and 
sufficient for high-specificity binding to a UAS (Ma and Ptashne, 1987). Gal4 can 
activate transcription in heterologous systems by using synthetic promoters consisting of 
basal transcription initiating elements combined with tandem repeats of the UAS 
sequence (Fischer et al., 1988; Kakidani and Ptashne, 1988; Lin et al., 1988; Ma et al., 
1988; Sadowski et al., 1988). Modified Gal4-based chimeric proteins comprising the 
Gal4 DBD fused to the strong transcriptional activation domain from the viral VP16 





1993; Wang et al., 1994). The Gal4/UAS system can be readily adaptable for transgenesis 
studies in diverse biological systems given that any gene of interest can be inserted 
downstream of a UAS/minimal promoter cassette. 
 
In the Gal4/UAS system, the spatial domain of UAS-controlled transgene expression is 
determined by the promoter used to express Gal4 (Brand and Perrimon, 1993). Additional 
refinements of the Gal4/UAS system provide temporal control of transgene expression. 
Taking advantage of the modular nature of Gal4 (Ma and Ptashne, 1987) and steroid 
hormone receptors (Webster et al., 1988), chimeric proteins have been produced that fuse 
the hormone binding domain from either the estrogen (ER) or glucocorticoid receptor 
(GR) to Gal4 (Webster et al., 1988). The resulting Gal4-ER and Gal4-GR fusion proteins 
activate UAS-controlled reporter genes only in the presence of the cognate steroid 
hormone (Louvion et al., 1993; Webster et al., 1988). To overcome effects of endogenous 
steroid hormones on Gal4-ER chimeras, an ER variant (known as ERT) with reduced 
affinity for naturally occurring estradiol but very high affinity for the estradiol analogs 
tamoxifen and 4-hydroxy tamoxifen (4-OHT) has been developed (Danielian et al., 1993; 
Feil et al., 1997).  The collective features of Gal4-ERT-VP16 fusion proteins make them 
a potent, highly specific, and tightly controllable tool for transgene expression upon 
administration of either tamoxifen or 4-OHT (Danielian et al., 1993; Feil et al., 1997; 
Louvion et al., 1993; Wang et al., 1994; Webster et al., 1988). 
 
The Gal4/UAS system has been adapted for use in zebrafish (Halpern et al., 2008; Scheer 





express, for example, wild-type or mutant proteins, fluorescent markers, and Cre 
recombinase for lineage-tracing studies. However, a search of available zebrafish lines 
from the Zebrafish International Resource Center (ZIRC) yields only a handful of Gal4 
lines that use unique, well-characterized promoters. Further, the majority of available 
Gal4 lines lack the ability to control the timing of gene expression. This is particularly 
problematic for larval or adult studies when phenotypes arising from earlier transgene 
expression obscure or exclude the later studies. Inducible Gal4/UAS switches in zebrafish 
designed to overcome this problem rely on heat shock promoter control of Gal4 
expression (Halloran et al., 2000). This approach produces strong expression but suffers 
from several major disadvantages, including a lack of cell-type specificity, poor control 
of expression kinetics, and spurious effects of repeated heat shocks. 
 
To overcome these limitations, we adapted the tamoxifen controlled Gal4-ERT system 
for use in zebrafish. We describe the generation and characterization of three tissue 
specific tamoxifen-dependent Gal4-ERT driver lines. These lines achieve rapid, dose-
dependent expression of UAS-controlled transgenes by simply adding tamoxifen or 4-
OHT to zebrafish water. We also validate this approach for functional analysis by 
demonstrating that tamoxifen dependent, tissue-specific expression of a constitutively 
active intracellular Notch domain (NICD) produces dramatic defects in notochord 
development. This effect requires NICD expression during an early developmental 
window prior to 10 hpf. The tamoxifen-dependent Gal4-ERT system affords zebrafish 
researchers the ability to address many biological questions previously limited by 






MATERIALS AND METHODS 
Zebrafish  
This study was carried out in strict accordance with the recommendations in the Guide 
for the Care and Use of Laboratory Animals (National Academies Press) and all steps 
were taken to minimize animal discomfort. Zebrafish were euthanized by overdose with 
Tricaine. The University of Oregon Institutional Animal Care and Use Committee 
(IACUC) approved all protocols. PHS assurance number for animal research: A-3009-01. 
The following established lines were used in this study: wild-type AB, 
Tg(5xUAS:EGFP)zf82 (Asakawa et al., 2008), Tg(14xUAS:LOX2272-LOXP-RFP-
LOX2272-CFP-LOXP-YFP)a130 (UAS:Zebrabow) (Pan et al., 2013), and Tg(5xUAS-
E1b:6xMYC-notch1a)kca3 (Scheer and Campos-Ortega, 1999). 
  
Transgene construction 
The Gateway cloning system (Invitrogen, Carlsbad, CA) and Tol2 kit (Kwan et al., 2007) 
was used to generate transgenes capable of tamoxifen-dependent expression. First, the 
coding sequence for the hybrid transcription factor, Gal4-ERT2-VP16 (Feil et al., 1997; 
Louvion et al., 1993) was inserted into ME-MCS to generate the middle element vector 
pME-Gal4-ERT-VP16. 5E vectors were constructed as follows: A region of the krt5 
promoter (Wang et al., 2006a) at chr23:10,284,249-10,286,542  (Zv9/danRer7) that 
drives expression in the epidermis was amplified by PCR from zebrafish genomic DNA 
and cloned into the Gateway compatible vector p5E-MCS (Kwan et al., 2007) to generate 





et al., 2007) at chr25: 18,817,373-18,827,789 (Zv9/danRer7) has been described 
previously (Stewart and Stankunas, 2012); the semi-ubiquitous hybrid promoter, made up 
of the frog ef1a enhancer and the rabbit b-globin intron, from pT2AL200R150G (Urasaki 
et al., 2006) was inserted into p5E-MCS creating p5E-ef1a. Finally, we used Gateway 
Clonase LRII enzyme (Invitrogen, Carlsbad, CA) to recombine each of 5E-krt5, 5E-efla, 
or 5E-dusp6 promoter elements with ME-Gal4TVP16, 3E-polyA (Kwan et al., 2007), and 
a modified Tol2 destination vector containing a myl7-ECFP cassette as a marker for 
transgenesis (Stewart and Stankunas, 2012).   
 
Generation of transgenic animals 
Plasmid DNA for each construct was co-injected with capped RNA coding for the Tc 
transposase into one cell stage AB embryos at a concentration of 25 ng/µl as described 
previously (Stewart and Stankunas, 2012). Animals displaying ECFP expression in the 
heart at 48 hpf were selected and reared to adulthood. Founders were identified by 
crossing to Tg(5xUAS:EGFP) animals, treating progeny with tamoxifen (3 µM, Sigma) at 
8 hpf, and visualizing EGFP expression at 24-48 hpf. Founders with EGFP-positive 
progeny were then outcrossed to AB fish. The subsequent generation was screened for 
single transgenic insertions by again crossing to Tg(5xUAS:EGFP) fish, treating embryo 
progeny with tamoxifen, and scoring the clutch for EGFP expression. Stable lines were 
maintained as heterozygotes by outcrossing to AB fish and picking animals with ECFP 








Induction of transgenes by tamoxifen 
For studies using embryos, 4-hydroxy-tamoxifen (4-OHT, Sigma) was dissolved in 
ethanol and added directly to the fish water at the times and concentrations indicated in 
the figure legends. Control animals were treated with the same volume of ethanol. For 
adult studies, tamoxifen (Sigma) dissolved in DMSO or 4-OHT dissolved in ethanol was 
added to fish water at a final concentration of 1 µM for 1 hour, after which animals were 
transferred to fresh fish water. Control animals were treated in the same manner with the 
same volume of vehicle. Animals were subjected to this regimen 3 consecutive days prior 
to imaging and tissue harvesting.  
 
Immunostaining and imaging 
For immunostaining embryos, animals were manually dechorionated and then fixed 
overnight at 4°C in phosphate-buffered saline (PBS) containing 4% paraformaldehyde. 
The next day, embryos were washed extensively in PBS containing 0.1% Tween-20 
(PBST) then dehydrated though a methanol series. Embryos in 100% methanol were then 
transferred to -20°C for at least 24 h prior to rehydration to PBST. Embryos were 
incubated in blocking buffer (PBST containing 10% normal goat serum) for 1-2 h at 
room temperature with gentle mixing. Primary antibodies were sourced and diluted as 
follows in blocking buffer and then incubated overnight at 4°C: anti-GFP (1:1000, Aves 
Labs), anti-myc epitope (1:1000, Invitrogen). The next day embryos were washed 2 x 30’ 
in PBST followed by 2 h room temperature incubation in Alexa-conjugated secondary 





30’ in PBST, 30’ in PBS, mounted in low melt agarose, and imaged on a Nikon Eclipse 
Ti widefield inverted microscope. For Figures 1, 2, 3, and S2A, C, D-G, embryos were 
fixed as above, washed in PBS, mounted in low melt agarose, and the native fluorescence 
of marker proteins visualized by epifluorescent microscopy. For scoring phenotypes, 
animals were manually dechorionated and counted under a stereomicroscope. Adult 
animals were anesthetized with Tricaine and imaged under a Leica M165 FC 
stereomicroscope. 
 
For paraffin-embedded eye sections, tamoxifen and control animals were sacrificed and 
eyes were immediately dissected and fixed overnight at 4°C in PBS containing 4% 
paraformaldehyde. The next day, samples were extensively washed in PBS, dehydrated, 
and embedded in paraffin. 7 µM sections were collected. Rehydrated sections were 
subjected to antigen retrieval by incubating in 0.25% trypsin for 20’ at 37°C, 
immunostaining with GFP and c-myc antibodies (described above), stained with Hoechst 
to label nuclei, mounted with Fluorogel (EMS), and imaged on a Leica DM4000B 
widefield microscope.   
 
Quantification of EGFP expression 
High magnification images of ventral EGFP-labeled epidermal cells were captured with a 
Nikon Eclipse Ti widefield inverted microscope. Unprocessed images from four 
representative animals for each tamoxifen dose were then analyzed using the ImageJ 
(NIH) software package to generate pixel intensity values based on the strength of the 





normalized to that of the lowest tamoxifen dose (0.5 µM) and plotted as “relative 
fluorescent intensity”.     
 
In situ hybridization 
In situ hybridizations were performed essentially as described by Thisse and Thisse  
(Thisse and Thisse, 2008a). Stained embryos were dehydrated in a methanol series and 
stored overnight at -20°C. Embryos were then rehydrated into PBST and transferred to 
100% glycerol. Equilibrated embryos were mounted in glycerol and imaged using 
Rottermann contrast optics on a Leica M165 FC stereomicroscope. 
 
RESULTS AND DISCUSSION 
Novel transgenic lines confer tamoxifen-dependent gene expression 
We combined features of the widely used Gal4/UAS and ER-tamoxifen systems and 
adapted them for use in transgenic zebrafish (Figure 1A). As a first step, we established 
transgenic zebrafish expressing the tamoxifen-dependent Gal4-ERT transcription factor 
(Danielian et al., 1993; Feil et al., 1997; Louvion et al., 1993; Wang et al., 1994; Webster 
et al., 1988) in various tissues and cell types. To generate a broadly expressing Gal4-ERT 
line for temporal studies, we used a 1.1 kb region from the Xenopus laevis elongation 
factor 1 alpha (ef1α) promoter and rabbit b-globin intron sequence (Urasaki et al., 2006).  
Additionally, we made a Gal4-ERT line driven by a 2.3 kb promoter region from the 
keratin 5 (krt5) gene that has been reported to express in the epidermis exclusively 
(Wang et al., 2006b). Finally, we produced a line expressing Gal4 under the control of a 





as Mkp3) is an FGF signaling responsive gene that is active in a variety of cells 
depending on the developmental stage and is induced in regenerating fins (Molina et al., 
2007; Stewart and Stankunas, 2012; Tsang et al., 2004).  
 
Figure 1. Temporally and spatially controlled transgene expression in zebrafish.   
(A) Schematic of transgenic constructs used in the Gal4-ERT system. A tamoxifen-responsive Gal4-ERT-
VP16 construct is expressed from a tissue-specific promoter that activates any UAS-linked responder line 
(shown here as a 5xUAS:EGFP reporter) upon tamoxifen or 4-OHT exposure (orange squares). The 
myl7:ECFP cassette serves as a transgenesis marker for the Gal4-ERT lines. (B-D) Visualization of EGFP 
expression in Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) animals treated with ethanol (B) or 2 µM 4-OHT (C 
and D) from 4-24 hpf. The white arrow in panel D highlights expression of EGFP in the epidermis. (E-I) 
EGFP expression in Tg(dusp6:Gal4-ERT-VP16; UAS:EGFP) animals treated with vehicle (E) or 2 µM 4-
OHT (F-I) from 4-24 hpf. In panels G and H, the white arrow indicates EGFP expression in the hindbrain 
and midbrain-hindbrain boundary. In panel I, arrowheads mark dorsal spinal cord neurons and the arrow 
points to EGFP expression in the floor plate. (J-M) Expression of EGFP in control (J) and 4-OHT treated 
(2 µM, K-M) Tg(ef1α:Gal4-ERT-VP16; UAS:EGFP) animals in a variety of cell types throughout the 
embryo including skeletal muscle (K, white arrow), the eye (L, white arrow), and the midbrain/ midbrain-
hindbrain boundary (M, white arrow). In panels B, E, and J, blue arrows point to myocardial ECFP 
expression, which represents the marker for transgenesis and serves as an internal control 
We crossed each of these driver lines to a Tg(UAS:EGFP) reporter line (Asakawa et al., 
2008) and treated embryos with 2 µM 4-hydroxytamoxifen (4-OHT) from 4-24 hours 





patterns in 25% of the fish, as expected from heterozygote intercrosses. Tg(krt5:Gal4-
ERT-VP16; UAS-EGFP) fish exhibited strong signal solely in the epidermis (Figure 1B-
D), mimicking the endogenous krt5 mRNA expression pattern (Wang et al., 2006b) 
(Figure S1). The Tg(krt5:Gal4-ERT-VP16) line was equally effective at producing a 
robust response when paired with additional UAS reporter lines (Figure S2A-C). 
Tg(dusp6:Gal4-ERT-VP16; UAS-EGFP) fish expressed EGFP in the expected pattern in 
the hindbrain, midbrain-hindbrain boundary, pharyngeal endoderm, notochord, and floor 
plate along with select dorsal motor neurons (Figure 1E-I) (Tsang et al., 2004). Although 
not ubiquitously expressed, the Tg(ef1α:Gal4-ERT-VP16; UAS-EGFP) line displayed 
EGFP expression in a wide variety of cell types throughout the embryo including those of 
the hindbrain, midbrain-hindbrain boundary, skeletal muscle and retina (Figure 1J-M). 
Unfortunately, the Tg(ef1α:Gal4-ERT-VP16) line becomes silenced prior to 48 hpf and is 
therefore only useful for early embryonic studies. In the absence of 4-OHT, no UAS-
EGFP expression was detected with any of the Gal4-ERT lines; only the cardiac-specific 
myl7:ECFP which we employed as a transgenesis marker was observed (Figure 1B, 1E, 
and 1J). Additionally, we saw no indication of 4-OHT toxicity with any of the treatments. 
These results demonstrate that each of the Gal4-ERT lines provide the expected tissue 
specificity and strictly require 4-OHT for UAS-dependent transgene expression. 
 
The Gal4-ERT system provides rapid induction of gene expression 
We next sought to determine the temporal resolution of the Gal4-ERT system by 
measuring how rapidly it can drive expression of UAS:EGFP in the presence of estradiol 





water containing 2 µM 4-OHT and monitored the emergence of EGFP expression. EGFP 
was first detected in the epidermis three hours post treatment. However, the expression 
was faint and non-homogenous (Figure 2C and 2C’). By four and a half hours post 4-
OHT exposure, EGFP expression was markedly more robust and labeled nearly the entire 
epidermis (Figure 2D and 2D’). These results indicate that the Gal4-ERT system 
possesses activation kinetics suitable for time-sensitive studies of rapidly developing 
zebrafish embryos.  
 
Figure 2. The Gal4-ERT system provides rapid induction of gene expression. 
(A-D) Kinetics of EGFP expression in Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) animals upon administration 
of 2 µM 4-OHT at 24 hpf for 0-4.5 hours. (A’-D’) High magnification images demonstrating EGFP 
expression for each treatment. White arrowheads point to epidermal expression of EGFP; blue arrows 
indicate bleed-through from the heart muscle-specific ECFP transgenesis marker. 
 
Transgene expression levels can be varied by tamoxifen dosage 
In addition to spatiotemporal control over transgene expression, it is often desirable to 
control levels of transgene expression. Therefore, we determined if varying the dose of 4-





VP16; UAS:EGFP) embryos at sphere-stage with various concentrations of 4-OHT. At 
24 hpf, embryos were harvested and fixed for imaging. We determined the fraction of 
EGFP-expressing epidermal cells and measured their normalized EGFP intensity. 4-OHT 
concentrations of 0.25 µM failed to produce detectable EGFP expression (data not 
shown). Embryos treated with 0.5 µM 4-OHT exhibited low-level EGFP in all 
presumptive epidermal cells (Figure 3A-B). Increasing the 4-OHT dose to 1 µM or 2 µM 
produced a relative gain in EGFP signal intensity with no indication of toxic effects 
(Figure 3C-E). Overall, increasing the dose from 0.5 µM to 2 µM yielded a 28% increase 
in EGFP levels (p < 0.05). At all effective concentrations, EGFP levels differed from 
cell-to-cell, which may reflect varying EGFP accumulation depending on cell cycle stage 
and the time lapse since a given epidermal cell was established and initiated krt5 
promoter activity. We repeated the experiment using Tg(krt5:Gal4-ERT-VP16; 
UAS:Zebrabow) fish, which expressed mCherry in the majority of epidermal cells when 
exposed to 0.5 µM 4-OHT (Figure S2D-E). Treating animals with 1 or 2 µM 4-OHT 
again produced notably higher mCherry expression levels and no sign of toxic effects 
(Figure S2F-G). Together, these results indicate that the Gal4-ERT system can be used to 







Figure 3. Transgene expression levels depend upon 4-OHT dosage. 
(A-D) EGFP expression upon treatment of Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) zebrafish with ethanol or 
the indicated dose of 4-OHT from 4-24 hpf. The blue arrow indicates myl7:ECFP expression. (A’-D’) 
High-magnification images of ventral epidermis from fish in each treatment group. (E) Normalized EGFP 
intensity (to the 0.5 µM 4-OHT treated group) of fish treated with ethanol or 4-OHT. Error bars represent 
standard deviations. 
 
Inducible transgene expression in adult zebrafish 
While the zebrafish was developed as a model organism for developmental studies 
(Grunwald and Eisen, 2002), recent years have seen an increased use of zebrafish larvae 
and adults for behavioral, physiologic, and disease modeling (e.g. cancer) research. 
Further, given their remarkable ability to regenerate damaged organs, adult zebrafish 
have become a leading vertebrate model for regeneration studies (Gemberling et al., 
2013). Therefore, we investigated the efficacy of the Gal4-ERT system in adult animals. 
We allowed Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) fish to develop to adulthood and 
induced Gal4-ERT activity by the addition of 1 µM tamoxifen for one hour per day over 
three days and monitored the fish for EGFP expression. Although the pattern of krt5 





observe that, in contrast to developing embryos/larvae, EGFP was not expressed in the 
epidermis. Rather, tamoxifen-exposed Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) adult fish 
showed restricted EGFP expression in the eye that was drug dependent and increased in 
intensity following each treatment (Figure 4A-D). Treatment with 1 µM 4-OHT produced 
similar results (data not shown). A histological analysis of the eyes from tamoxifen-
exposed Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) fish revealed that EGFP was most 
notably induced in the photoreceptors, accumulating in the inner segment (Figure 4E-H). 
By in situ hybridization, EGFP transcripts remained present in the photoreceptors eight 
hours after treatment, which suggests that even transient tamoxifen exposure (only one 
hour) is sufficient to elicit robust transgene activation in adults with little or no 
background (Figure 4I). While we were unable to establish if endogenous krt5 is 
similarly expressed, the Tg(krt5:Gal4-ERT-VP16) line provides a valuable tool for 
inducible transgene expression in adult zebrafish photoreceptors. More generally, our 
results validate use of the Gal4-ERT system for spatiotemporal control of transgene 
expression in adult zebrafish using small molecules. 
 
Figure 4. Inducible transgene expression in adult zebrafish. 
(A-D) Expression of EGFP in the eye of a single adult Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) zebrafish 
prior to (A and B) and after (C and D) treatment with 1 µM tamoxifen for one hour per day for three 
consecutive days. Green arrows point to EGFP expression in the eye. The areas bounded by the dashed red 
box in A and C are shown at high magnification in B and D, respectively. (E-H) Immunostaining of 
paraffin sections with anti-EGFP antibodies (shown in green) in eyes from DMSO- (E and F) and 
tamoxifen-treated (G and H) Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) fish. Panels F and H show overlays 
with anti-EGFP antibody staining in green, Hoechst-stained nuclei in blue, and auto-fluorescence in red. 
Fish were drug treated as in A-D. Green arrows indicate EGFP expression in photoreceptors and asterisks 
(*) denote auto-fluorescence in photoreceptor outer segments. (I) In situ hybridization for EGFP mRNA in 






Using inducible expression to define temporal roles of Notch signaling 
The high degree of spatiotemporal control over UAS-linked reporters prompted us to 
ascertain if the system is capable of generating inducible gain-of-function phenotypes. 
During zebrafish embryogenesis, the organizer forms the notochord, floor plate, and 
hypochord (Melby et al., 1996). Previous studies have established that the Notch 





and floor plate at the expense of the notochord (Latimer and Appel, 2006; Yamamoto et 
al., 2010). In support of this model, Tg(hsp:Gal4; UAS:NICD) fish ubiquitously 
overexpressing the Notch1a intracellular domain (NICD) following heat shock (Coffman 
et al., 1993; Lieber et al., 1993; Rebay et al., 1993; Scheer and Campos-Ortega, 1999; 
Struhl et al., 1993), display a dramatically reduced trunk notochord (Latimer and Appel, 
2006). Given that Tg(dusp6:Gal4-ERT-VP16; UAS:EGFP) embryos exposed to 4-OHT 
from 0-12 hpf exhibited robust EGFP expression in the trunk midline (Figure 5A and 
5B), mimicking endogenous dusp6 (Tsang et al., 2004), we hypothesized expression of 
activated Notch1a within dusp6+ cells would produce notochord developmental defects. 
We crossed Tg(dusp6:Gal4-ERT-VP16) to Tg(UAS:NICD) fish and treated resulting 
embryos with either vehicle or 4 µM 4-OHT beginning at 2 hpf. By 24 hpf, 4-OHT 
treated embryos were noticeably smaller than controls and had reduced and/or malformed 
notochords containing misshapen cells (Figure 5C-F), a phenotype reminiscent of that 
described upon global overexpression of NICD (Latimer and Appel, 2006; Yamamoto et 
al., 2010). Such notochord defects were observed in 27% (29/110) of 4-OHT treated 
embryos at 48 hpf (Figure S3). As 25% of the embryos would carry both transgenes, the 
phenotype was fully penetrant. Ethanol treated embryos from the same clutch had no 
notochord defects (0/100). Tg(krt5:Gal4-ERT; UAS:NICD) animals expressing NICD in 
the epidermis following the identical 4-OHT regimen also had normal notochords (Figure 
S3E-F). These studies show that NICD expression in midline cells is sufficient to disrupt 







Figure 5. Overexpression of the Notch1 intracellular domain using the dusp6:Gal4-ERT driver 
disrupts notochord development. 
(A and B) EGFP expression at the 10-somite stage in control (A) and 2 µM 4-OHT treated Tg(dusp6:Gal4-
ERT-VP16; UAS:EGFP) fish. The green arrow points to EGFP expression at the midline. (C-F) DIC 
images of control (C and D) and 4-OHT treated (4 µM from 2-24 hpf, E and F) Tg(dusp6:Gal4-ERT-VP16; 
UAS:NICD) animals at 24 hpf. Regions bounded by the dashed red box in panels C and E are shown in 
high magnification in panels D and F, respectively. In panel D, the red arrow indicates the floor plate (fp) 
and the blue arrow indicates the notochord (nc); in panel E, the magenta arrow highlights the reduced 
notochord and disorganized floor plate. 
 
Lastly, we tested whether the inducible Gal4-ERT system could be used to map the 
developmental window in which notochord development is sensitive to elevated Notch 
signaling. We treated embryos with vehicle or 4-OHT at 4 hpf, 6 hpf, 8 hpf, or 10 hpf and 
scored fish for a notochord reduction phenotype at 24 hpf. The frequency of notochord 
defects remained constant when embryos were treated with 4-OHT at or before 6 hpf 
(occurring in approximately 25% of embryos, the expected frequency of double 





treatment began at 8 hpf and approached zero when fish were first exposed at 10 hpf 
(Figure 6A-E, relative penetrance plotted in F). By immunostaining for the myc tag on 
the NICD transgene, we confirmed that these latter embryos expressed NICD (Figure 6A-
E), demonstrating that the lack of a phenotype when 4-OHT was added at 10 hpf was not 
due to a failure to induce NICD. In situ hybridization for the floor plate and notochord 
marker sonic hedgehog (shha) (Echelard et al., 1993; Krauss et al., 1993) further 
confirmed that the phenotype was fully suppressed when exposed to drug at 10 hpf in 
contrast to earlier treatments (Figure 6G-I). These results suggest that Notch activation 
within midline cells can inhibit notochord formation during gastrulation (between 5 and 
10 hpf). After this period, the cells are refractory to elevated levels of Notch signaling. 
These results are consistent with published data proposing that Notch mediates cell fate 
decision in the organizer between a notochord and hypochord fate (Appel et al., 1999; 
Latimer and Appel, 2006; Yamamoto et al., 2010). The tamoxifen-inducible NICD 
approach we describe could be a useful tool to help determine how Notch mediates this 
and other cell fate decisions. Generally, this study illustrates how an inducible Gal4-ERT 
system provides sufficient spatiotemporal control over transgene expression to map 
narrow windows of cell-type specific gene function. 
Figure 6. Using inducible expression to define temporal roles of Notch1 signaling in notochord 
development. 
(A-E) Expression of myc-tagged NICD by immunostaining with myc antibodies on 24 hpf Tg(dusp6:Gal4-
ERT-VP16; UAS:NICD) embryos treated with ethanol (A) or 4 µM 4-OHT at the indicated times (B-E). 
Blue arrows indicate myocardial ECFP expression to mark transgenic animals and magenta arrows show 
expression of myc-tagged NICD. Panel insets display high magnification images of boxed regions where 
red arrows indicates the notochord (A and E) and the missing notochord (B-D). (F) Penetrance of the 4-
OHT induced notochord defects in Tg(dusp6:Gal4-ERT-VP16; UAS:NICD) animals, treated with 4-OHT at 
various stages of development, is shown relative to the 4-24 hpf treatment (1.0 indicates complete 
penetrance). The double asterisk indicates a significant difference between 4-24 h and 10-24 h 4-OHT 
treated fish (P < 0.005). Individual points represent independent experiments with separate clutches. (G-I) 
Expression of shha in the floor plate of animals treated with ethanol (G) or with 4-OHT for the indicated 
times (H-I). Boxed regions are shown at higher magnification in the panel insets. Red arrows indicate shha 









Our results validate the use of the Gal4-ERT system in zebrafish by demonstrating how it 
can direct transgene expression in a cell-type specific and tamoxifen/4-OHT-dependent 
manner. The approach has substantial advantages over other methods to induce transgene 
expression in zebrafish, most notably heat shock sensitive promoters. First, the tamoxifen 
system is dose dependent and therefore transgene expression can be tuned to a desired 
level by titrating the concentration of tamoxifen/4-OHT added directly to the fish water.  
Second, at doses that activate Gal4-ERT, tamoxifen/4-OHT causes no adverse affects to 





zebrafish and may be detrimental to animal health and lead to mixed or obscured results. 
Finally, heat shock promoters are broadly expressed upon heat shock whereas tissue-
specificity is desired or required for many experiments. Tetracycline-inducible transgene 
expression represents a parallel methodology with similar advantages for zebrafish 
studies (Knopf et al., 2010), albeit with a more limited number of available Tet-
responsive transgenes.  Importantly, Gal4-ERT and Tet-On systems are orthogonal and 
could be used to independently induce expression of two transgenes either 
simultaneously or sequentially.  
 
Gerety et. al. (Gerety et al., 2013) have also demonstrated the feasibility of a Gal4-based 
tamoxifen inducible transgene system in zebrafish. There are similarities and differences 
between this report and our study. First, Gerety et al. (2013) use a ERT-Gal4 fused to two 
copies of a truncated VP16 transactivation domain (Asakawa et al., 2008) whereas we 
use Gal4-ERT fused to a single copy of a VP16 (Louvion et al., 1993). Despite these 
differences, both inducible Gal4-fusion proteins require similar concentrations of 4-OHT 
for transgene expression and the kinetics of induction are comparable (Gerety et al., 
2013). Gerety et al. (2013) additionally observe the reversal of gene expression following 
tamoxifen removal. The reversal kinetics may be slow, as we did not see a notable 
decrease in EGFP expression 24 hours after removing tamoxifen from embryos (data not 
shown), although the long half-life of EGFP protein complicates this analysis. Using a 
line (cldnb:ERT2-Gal4) directing Gal4-ERT expression primarily in the skin and lateral 
line, Gerety et al. (2013) show the approach can be used to drive tissue-specific 





ERT) that provide spatially restricted and tamoxifen-controlled transgene activation. We 
further validate using the Gal4-ERT system in adult zebrafish. Both reports demonstrate 
use of the Gal4-ERT system to generate gain-of-function phenotypes. We extend this 
approach to determine tissue-specific and temporal windows of gene function during 
development. Collectively, the two reports provide a robust validation of the capability 
and versatility of the Gal4-ERT system in zebrafish and provide an initial collection of 
transgenic tools for immediate use. 
 
Potential applications for Gal4-ERT inducible expression transcend the reporter and 
inducible gain-of-function experiments demonstrated to date. For example, the approach 
could be used for cell-specific loss-of-function studies by the inducible expression of 
dominant negative proteins, pathway inhibitors, or shRNAs for RNA interference. 
Additionally, the inducible expression of a UAS:Cre line in concert with floxed reporter 
lines could improve cell lineage analyses. Lastly, the utility of the system in adults opens 









 In Chapter II, I utilized contemporary genetic tools to 1) provide an in-depth 
comparison of loss-of-function methods to show that antisense morpholinos are prone to 
off-target effects in zebrafish and 2) describe novel findings regarding the in vivo roles of 
Kdm6b-demethylases during cardiovascular development and morphogenesis. I utilized 
CRISPR/Cas9 to generate loss-of-function models of both kdm6ba and its ohnolog 
kdm6bb and demonstrated that these genes function redundantly during late stage 
proliferation during heart ventricle maturation.  
 
 These results represent the first in vivo descriptions of Kdm6b demethylase 
function during cardiovascular development and support the hypothesis that the primary 
function of H3K27 demethylases is to contribute to late stage organ maturation rather 
than early lineage commitment and differentiation. These conclusions favor a model in 
which Kdm6b demethylases are dispensable for the events that shape the early embryo 
including proliferation, migration, and the regulation of cell fate decisions. Instead, my 
data suggests that Kdm6b demethylases promote a wave of proliferation and maturation 
that takes place only after the formation of the rudimentary heart. Furthermore, I show 
that H3K27me3 levels are retained in kdm6b-deficient trabeculating cardiomyocytes. 
Despite this clear correlation of proliferation and levels of H3K27me3, it will be 





demethylation within this context, or if its mechanism of action is demethylase 
independent.  
 
 In Chapter III, I demonstrate a novel transgenic tool based on a modified 
GAL4/UAS system that allows for the spatiotemporal control of transgene expression. 
My expression system uses new tissue-specific transgenic zebrafish lines that express the 
Gal4 transcription factor fused to the estrogen-binding domain of the human estrogen 
receptor. I show these Gal4-ERT driver lines confer rapid, tissue-specific induction of 
UAS-controlled transgenes following tamoxifen exposure in both embryos and adult fish. 
I demonstrate how this technology can be used to define developmental windows of gene 
function by spatiotemporal-controlled expression of constitutively active Notch1 in 
embryos. Given the array of existing UAS lines, the modular nature of this system will 






SUPPLEMENTAL MATERIAL (CHAPTER II) 
 
 
Figure S1. Morpholinos Mo 5 and Mo 6 prevent proper splicing of kdm6bb transcript 
(A) Schematic of Jmjc coding region of kdm6bb. (B) PCR on cDNA extracted from single morpholino-








Figure S2. Morphant phenotypes persist in kdm6bb mutant embryos 
Morpholino injections into both kdm6bb-/- and kdm6bb+/- clutch mates shown by whole mount DIC (A-D), 
Tg(flk:EGFP) reporter (A’-D’) and OFT immunostaining (A”-D”). Yellow arrows denote normal OFT and 








Figure S3. Morphant phenotypes persist in kdm6bb mutant embryos injected with morpholino #5 
Morpholino injections into both kdm6bb-/- and kdm6bb+/- clutch mates shown by whole mount DIC (A-D), 
Tg(flk:EGFP) reporter (A’-D’) and OFT immunostaining (A”-D”). Yellow arrows denote normal OFT and 







Figure S4.  Morpholino #5 does not appear to affect splicing of other kdm6b-family members 
PCR of cDNA along with schematic of the region amplified.  
 
 
Figure S5.  Early development of kdm6b-deficient embryos is unaffected 
(A-B) DIC images of 24 hpf (A) and 72 hpf (B) control embryos. (C-D) DIC images of kdm6b-deficient 







Figure S6.  5 dpf morphants and kdm6bb mutants show different craniofacial phenotypes that are 
not recapitulated in kdm6baMZ kdm6bb+/- embryos 
(A-C) 5 dpf DIC images of morphants and kdm6ba-/-;kdm6bb-/- double mutants. (D-F)  5dpf DIC images of 







Figure S7.  Decreased ventricular area in coronal sections of 7 dpf kdm6b-deficient embryos. 
(A-B) H&E of coronal sections of the ventricle at 7 dpf. (C) Quantified area of 7 dpf ventricular coronal 






SUPPLEMENTAL MATERIAL (CHAPTER III) 
 
 
Figure S1: krt5:Gal4-ERT expression matches that of endogenous krt5. 
(A-C) Whole mount in situ hybridization of GFP expression in ethanol (A) or 4-OHT-exposed 
(B) 24 hpf Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) embryos compared to endogenous krt5 








Figure S2: Multiple UAS reporter lines produce robust and dose dependent responses to 
activated Gal4-ERT. 
(A-C) The krt5:Gal4-ERT line is compatible with UAS:EGFP (A), UAS:NICD shown via anti-
Myc immunostaining (B), and UAS:Zebrabow (C) reporter lines at 36 hpf. (D-G) mCherry 
expression upon treatment of Tg(krt5:Gal4-ERT-VP16; UAS:Zebrabow) animals with ethanol or 













Figure S3: Tissue-specific notochord defects upon dusp6:Gal4-ERT driven NICD 
overexpression persist in 48 hpf zebrafish. 
(A-D) DIC images of Tg(dusp6:Gal4-ERT-VP16; UAS:NICD) animals treated with either ethanol 
(A-B) or 4 µM 4-OHT from 2-48 hpf (C-D). Boxed regions in A and C are shown in higher 
magnification in B and D respectively. Red arrows indicate notochord. Numbers in A and C 
reflect the quantity of animals displaying a notochord defect in each treated population (25% 
double transgenic animals). (E-G) Bright-field images overlaid with anti-myc immunostaining 
(magenta) of Tg(dusp6:Gal4-ERT-VP16; UAS:NICD) (E-F) and Tg(krt5:Gal4-ERT-VP16; 
UAS:NICD) (G) fish demonstrates that notochord defects are only observed when UAS:NICD is 
driven by the dusp6:Gal4-ERT cassette (F). Boxed regions are shown in higher magnification in 
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